Abstract

Absence of vascular-stent tissue coverage by IVOCT is a biomarker for potential stent-related thrombosis. We developed highly-automated algorithms to classify covered and uncovered struts and quantitatively evaluate stent apposition. We trained a machine learning model on 7,125 images, and included an active learning, relabeling step to improve noisy labels. We obtained uncovered strut classification sensitivity/specificity (94%/90%) comparable to analyst inter-and-intra-observer variability and AUC (0.97), and tissue coverage thickness measurement arguably better than the commercial product. By comparing classification models from regular and relabeled data sets, we observed robustness of the support vector machine to noisy data. A graph-based algorithm detected clusters of uncovered struts thought to pose a greater risk than isolated uncovered struts. The software enables highly-automated, objective, repeatable, comprehensive stent analysis.

© 2019 Optical Society of America under the terms of the OSA Open Access Publishing Agreement

Full Article  |  PDF Article
OSA Recommended Articles
Automatic stent detection in intravascular OCT images using bagged decision trees

Hong Lu, Madhusudhana Gargesha, Zhao Wang, Daniel Chamie, Guilherme F. Attizzani, Tomoaki Kanaya, Soumya Ray, Marco A. Costa, Andrew M. Rollins, Hiram G. Bezerra, and David L. Wilson
Biomed. Opt. Express 3(11) 2809-2824 (2012)

Automatic detection of bioresorbable vascular scaffold struts in intravascular optical coherence tomography pullback runs

Ancong Wang, Shimpei Nakatani, Jeroen Eggermont, Yoshi Onuma, Hector M. Garcia-Garcia, Patrick W. Serruys, Johan H.C. Reiber, and Jouke Dijkstra
Biomed. Opt. Express 5(10) 3589-3602 (2014)

Automated plaque characterization using deep learning on coronary intravascular optical coherence tomographic images

Juhwan Lee, David Prabhu, Chaitanya Kolluru, Yazan Gharaibeh, Vladislav N. Zimin, Hiram G. Bezerra, and David L. Wilson
Biomed. Opt. Express 10(12) 6497-6515 (2019)

References

  • View by:
  • |
  • |
  • |

  1. M. S. Chen, J. M. John, D. P. Chew, D. S. Lee, S. G. Ellis, and D. L. Bhatt, “Bare metal stent restenosis is not a benign clinical entity,” Am. Heart J. 151(6), 1260–1264 (2006).
    [Crossref] [PubMed]
  2. M. E. Pfisterer, “Late Stent Thrombosis After Drug-Eluting Stent Implantation for Acute Myocardial Infarction: A New Red Flag is Raised,” Circulation 118(11), 1117–1119 (2008).
    [Crossref] [PubMed]
  3. T. F. Lüscher, J. Steffel, F. R. Eberli, M. Joner, G. Nakazawa, F. C. Tanner, and R. Virmani, “Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications,” Circulation 115(8), 1051–1058 (2007).
    [Crossref] [PubMed]
  4. R. Waksman, “Biodegradable stents: they do their job and disappear,” J. Invasive Cardiol. 18(2), 70–74 (2006).
    [PubMed]
  5. P. W. Serruys, H. M. Garcia-Garcia, and Y. Onuma, “From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?” Eur. Heart J. 33(1), 16–25 (2012).
    [Crossref] [PubMed]
  6. S. McMahon, N. Bertollo, E. D. O. Cearbhaill, J. Salber, L. Pierucci, P. Duffy, T. Dürig, V. Bi, and W. Wang, “Bio-resorbable polymer stents: a review of material progress and prospects,” Prog. Polym. Sci. 83, 79–96 (2018).
    [Crossref]
  7. C. M. Felix, J. M. Fam, R. Diletti, Y. Ishibashi, A. Karanasos, B. R. C. Everaert, N. M. D. A. van Mieghem, J. Daemen, P. P. T. de Jaegere, F. Zijlstra, E. S. Regar, Y. Onuma, and R.-J. M. van Geuns, “Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry,” JACC Cardiovasc. Interv. 9(16), 1652–1663 (2016).
    [Crossref] [PubMed]
  8. J. M. Fam, C. Felix, R. J. van Geuns, Y. Onuma, N. M. Van Mieghem, A. Karanasos, J. van der Sijde, M. De Paolis, E. Regar, M. Valgimigli, J. Daemen, P. de Jaegere, F. Zijlstra, and R. Diletti, “Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study,” EuroIntervention 12(1), 30–37 (2016).
    [Crossref] [PubMed]
  9. D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
    [Crossref] [PubMed]
  10. Y. Ishibashi, S. Nakatani, and Y. Onuma, “Definite and probable bioresorbable scaffold thrombosis in stable and ACS patients,” EuroIntervention 11(3), e1–e2 (2015).
    [Crossref] [PubMed]
  11. Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
    [Crossref] [PubMed]
  12. B. Chevalier, Y. Onuma, A. J. van Boven, J. J. Piek, M. Sabaté, S. Helqvist, A. Baumbach, P. C. Smits, R. Kumar, L. Wasungu, and P. W. Serruys, “Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial,” EuroIntervention 12(9), 1102–1107 (2016).
    [Crossref] [PubMed]
  13. P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
    [Crossref] [PubMed]
  14. J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, F. D. Kolodgie, G. L. Kaluza, M. B. Leon, and R. Virmani, “Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix,” Circ. Cardiovasc. Interv. 3(3), 257–266 (2010).
    [Crossref] [PubMed]
  15. M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, and R. J. de Winter, “Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study,” Eur. Heart J. 31(9), 1055–1064 (2010).
    [Crossref] [PubMed]
  16. I.-K. Jang, B. E. Bouma, D.-H. Kang, S.-J. Park, S.-W. Park, K.-B. Seung, K.-B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S. L. Houser, H. T. Aretz, and G. J. Tearney, “Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound,” J. Am. Coll. Cardiol. 39(4), 604–609 (2002).
    [Crossref] [PubMed]
  17. H. G. Bezerra, M. A. Costa, G. Guagliumi, A. M. Rollins, and D. I. Simon, “Intracoronary optical coherence tomography: a comprehensive review clinical and research applications,” JACC Cardiovasc. Interv. 2(11), 1035–1046 (2009).
    [Crossref] [PubMed]
  18. M. Joner, A. V. Finn, A. Farb, E. K. Mont, F. D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H. K. Gold, and R. Virmani, “Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk,” J. Am. Coll. Cardiol. 48(1), 193–202 (2006).
    [Crossref] [PubMed]
  19. A. T. L. Ong, E. P. McFadden, E. Regar, P. P. T. de Jaegere, R. T. van Domburg, and P. W. Serruys, “Late angiographic stent thrombosis (LAST) events with drug-eluting stents,” J. Am. Coll. Cardiol. 45(12), 2088–2092 (2005).
    [Crossref] [PubMed]
  20. M. Pfisterer, H. P. Brunner-La Rocca, P. T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, C. Kaiser, and BASKET-LATE Investigators, “Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents,” J. Am. Coll. Cardiol. 48(12), 2584–2591 (2006).
    [Crossref] [PubMed]
  21. G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
    [Crossref] [PubMed]
  22. G. Guagliumi, V. Sirbu, G. Musumeci, R. Gerber, G. Biondi-Zoccai, H. Ikejima, E. Ladich, N. Lortkipanidze, A. Matiashvili, O. Valsecchi, R. Virmani, and G. W. Stone, “Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging,” JACC Cardiovasc. Interv. 5(1), 12–20 (2012).
    [Crossref] [PubMed]
  23. H. Lu, M. Gargesha, Z. Wang, D. Chamie, G. F. Attizzani, T. Kanaya, S. Ray, M. A. Costa, A. M. Rollins, H. G. Bezerra, and D. L. Wilson, “Automatic stent detection in intravascular OCT images using bagged decision trees,” Biomed. Opt. Express 3(11), 2809–2824 (2012).
    [Crossref] [PubMed]
  24. G. F. Attizzani and H. G. Bezerra, “Contemporary assessment of stent strut coverage by OCT,” Int. J. Cardiovasc. Imaging 29(1), 23–27 (2013).
    [Crossref] [PubMed]
  25. A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
    [Crossref] [PubMed]
  26. N. Bruining, K. Sihan, J. Ligthart, S. de Winter, and E. Regar, “Automated three-dimensional detection of intracoronary stent struts in optical coherence tomography images,” in 2011 Computing in Cardiology (2011), pp. 221–224.
  27. S. Tsantis, G. C. Kagadis, K. Katsanos, D. Karnabatidis, G. Bourantas, and G. C. Nikiforidis, “Automatic vessel lumen segmentation and stent strut detection in intravascular optical coherence tomography,” Med. Phys. 39(1), 503–513 (2011).
    [Crossref] [PubMed]
  28. C. Xu, J. M. Schmitt, T. Akasaka, T. Kubo, and K. Huang, “Automatic detection of stent struts with thick neointimal growth in intravascular optical coherence tomography image sequences,” Phys. Med. Biol. 56(20), 6665–6675 (2011).
    [Crossref] [PubMed]
  29. S. Gurmeric, G. G. Isguder, S. Carlier, and G. Unal, “A new 3-D automated computational method to evaluate in-stent neointimal hyperplasia in in-vivo intravascular optical coherence tomography pullbacks,” Med Image Comput Comput Assist Interv 12(Pt 2), 776–785 (2009).
  30. M. W. Zhao Wang, G. C. Jenkins, H. G. Linderman, Y. Bezerra, M. A. Fujino, D. L. Costa, Wilson, and A. M. Rollins, “3-D Stent Detection in Intravascular OCT Using a Bayesian Network and Graph Search,” IEEE Trans. Med. Imaging 34(7), 1549–1561 (2015).
    [Crossref] [PubMed]
  31. G. J. Ughi, C. J. Van Dyck, T. Adriaenssens, V. Y. Hoymans, P. Sinnaeve, J.-P. Timmermans, W. Desmet, C. J. Vrints, and J. D’hooge, “Automatic assessment of stent neointimal coverage by intravascular optical coherence tomography,” Eur. Heart J. Cardiovasc. Imaging 15(2), 195–200 (2014).
    [Crossref] [PubMed]
  32. T. Adriaenssens, G. J. Ughi, C. Dubois, K. Onsea, D. De Cock, J. Bennett, S. Wiyono, M. Vanhaverbeke, P. Sinnaeve, A. Belmans, J. D’hooge, and W. Desmet, “Automated detection and quantification of clusters of malapposed and uncovered intracoronary stent struts assessed with optical coherence tomography,” Int. J. Cardiovasc. Imaging 30(5), 839–848 (2014).
    [Crossref] [PubMed]
  33. H. S. Nam, C.-S. Kim, J. J. Lee, J. W. Song, J. W. Kim, and H. Yoo, “Automated detection of vessel lumen and stent struts in intravascular optical coherence tomography to evaluate stent apposition and neointimal coverage,” Med. Phys. 43(4), 1662–1675 (2016).
    [Crossref] [PubMed]
  34. A. Wang, S. Nakatani, J. Eggermont, Y. Onuma, H. M. Garcia-Garcia, P. W. Serruys, J. H. C. Reiber, and J. Dijkstra, “Automatic detection of bioresorbable vascular scaffold struts in intravascular optical coherence tomography pullback runs,” Biomed. Opt. Express 5(10), 3589–3602 (2014).
    [Crossref] [PubMed]
  35. J. M. Amrute, L. S. Athanasiou, F. Rikhtegar, J. M. de la Torre Hernández, T. G. Camarero, and E. R. Edelman, “Polymeric endovascular strut and lumen detection algorithm for intracoronary optical coherence tomography images,” J. Biomed. Opt. 23(3), 1–14 (2018).
    [Crossref] [PubMed]
  36. R. Shalev, H. G. Bezerra, S. Ray, D. Prabhu, and D. L. Wilson, “Classification of calcium in intravascular OCT images for the purpose of intervention planning,” Proc SPIE Int Soc Opt Eng9786, (2016).
  37. C. Kolluru, D. Prabhu, Y. Gharaibeh, H. Wu, and D. L. Wilson, “Voxel-based plaque classification in coronary intravascular optical coherence tomography images using decision trees,” Proc SPIE Int Soc Opt Eng10575, (2018).
    [Crossref]
  38. C. Kolluru, D. Prabhu, Y. Gharaibeh, H. Bezerra, G. Guagliumi, and D. Wilson, “Deep neural networks for A-line-based plaque classification in coronary intravascular optical coherence tomography images,” J. Med. Imaging (Bellingham) 5(4), 044504 (2018).
    [Crossref] [PubMed]
  39. Z. Wang, D. Chamie, H. G. Bezerra, H. Yamamoto, J. Kanovsky, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Volumetric quantification of fibrous caps using intravascular optical coherence tomography,” Biomed. Opt. Express 3(6), 1413–1426 (2012).
    [Crossref] [PubMed]
  40. Z. Wang, H. Kyono, H. G. Bezerra, H. Wang, M. Gargesha, C. Alraies, C. Xu, J. M. Schmitt, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Semiautomatic segmentation and quantification of calcified plaques in intracoronary optical coherence tomography images,” J. Biomed. Opt. 15(6), 061711 (2010).
    [Crossref] [PubMed]
  41. D. Prabhu, E. Mehanna, M. Gargesha, D. Wen, E. Brandt, N. S. van Ditzhuijzen, D. Chamie, H. Yamamoto, Y. Fujino, A. Farmazilian, J. Patel, M. Costa, H. G. Bezerra, and D. L. Wilson, “3D registration of intravascular optical coherence tomography and cryo-image volumes for microscopic-resolution validation,” Proc SPIE Int Soc Opt Eng9788, (2016).
  42. R. Shalev, D. Prabhu, K. Tanaka, A. M. Rollins, M. Costa, H. G. Bezerra, R. Soumya, and D. L. Wilson, “Intravascular optical coherence tomography image analysis method,” in 2015 41st Annual Northeast Biomedical Engineering Conference (NEBEC) (2015), pp. 1–2.
    [Crossref]
  43. V. N. Vapnik, “An overview of statistical learning theory,” IEEE Trans. Neural Netw. 10(5), 988–999 (1999).
    [Crossref] [PubMed]
  44. C. M. Bishop, Pattern Recognition and Machine Learning (Information Science and Statistics) (Springer-Verlag, 2006).
  45. C. J. C. Burges, “A Tutorial on Support Vector Machines for Pattern Recognition,” Data Min. Knowl. Discov. 2(2), 121–167 (1998).
    [Crossref]
  46. C.-C. Chang and C.-J. Lin, “LIBSVM: A Library for Support Vector Machines,” ACM Trans. Intell. Syst. Technol. 2(3), 27:1–27:27 (2011).
    [Crossref]
  47. A. V. Finn, M. Joner, G. Nakazawa, F. Kolodgie, J. Newell, M. C. John, H. K. Gold, and R. Virmani, “Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization,” Circulation 115(18), 2435–2441 (2007).
    [Crossref] [PubMed]

2018 (3)

S. McMahon, N. Bertollo, E. D. O. Cearbhaill, J. Salber, L. Pierucci, P. Duffy, T. Dürig, V. Bi, and W. Wang, “Bio-resorbable polymer stents: a review of material progress and prospects,” Prog. Polym. Sci. 83, 79–96 (2018).
[Crossref]

J. M. Amrute, L. S. Athanasiou, F. Rikhtegar, J. M. de la Torre Hernández, T. G. Camarero, and E. R. Edelman, “Polymeric endovascular strut and lumen detection algorithm for intracoronary optical coherence tomography images,” J. Biomed. Opt. 23(3), 1–14 (2018).
[Crossref] [PubMed]

C. Kolluru, D. Prabhu, Y. Gharaibeh, H. Bezerra, G. Guagliumi, and D. Wilson, “Deep neural networks for A-line-based plaque classification in coronary intravascular optical coherence tomography images,” J. Med. Imaging (Bellingham) 5(4), 044504 (2018).
[Crossref] [PubMed]

2016 (6)

H. S. Nam, C.-S. Kim, J. J. Lee, J. W. Song, J. W. Kim, and H. Yoo, “Automated detection of vessel lumen and stent struts in intravascular optical coherence tomography to evaluate stent apposition and neointimal coverage,” Med. Phys. 43(4), 1662–1675 (2016).
[Crossref] [PubMed]

C. M. Felix, J. M. Fam, R. Diletti, Y. Ishibashi, A. Karanasos, B. R. C. Everaert, N. M. D. A. van Mieghem, J. Daemen, P. P. T. de Jaegere, F. Zijlstra, E. S. Regar, Y. Onuma, and R.-J. M. van Geuns, “Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry,” JACC Cardiovasc. Interv. 9(16), 1652–1663 (2016).
[Crossref] [PubMed]

J. M. Fam, C. Felix, R. J. van Geuns, Y. Onuma, N. M. Van Mieghem, A. Karanasos, J. van der Sijde, M. De Paolis, E. Regar, M. Valgimigli, J. Daemen, P. de Jaegere, F. Zijlstra, and R. Diletti, “Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study,” EuroIntervention 12(1), 30–37 (2016).
[Crossref] [PubMed]

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

B. Chevalier, Y. Onuma, A. J. van Boven, J. J. Piek, M. Sabaté, S. Helqvist, A. Baumbach, P. C. Smits, R. Kumar, L. Wasungu, and P. W. Serruys, “Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial,” EuroIntervention 12(9), 1102–1107 (2016).
[Crossref] [PubMed]

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

2015 (3)

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Y. Ishibashi, S. Nakatani, and Y. Onuma, “Definite and probable bioresorbable scaffold thrombosis in stable and ACS patients,” EuroIntervention 11(3), e1–e2 (2015).
[Crossref] [PubMed]

M. W. Zhao Wang, G. C. Jenkins, H. G. Linderman, Y. Bezerra, M. A. Fujino, D. L. Costa, Wilson, and A. M. Rollins, “3-D Stent Detection in Intravascular OCT Using a Bayesian Network and Graph Search,” IEEE Trans. Med. Imaging 34(7), 1549–1561 (2015).
[Crossref] [PubMed]

2014 (3)

G. J. Ughi, C. J. Van Dyck, T. Adriaenssens, V. Y. Hoymans, P. Sinnaeve, J.-P. Timmermans, W. Desmet, C. J. Vrints, and J. D’hooge, “Automatic assessment of stent neointimal coverage by intravascular optical coherence tomography,” Eur. Heart J. Cardiovasc. Imaging 15(2), 195–200 (2014).
[Crossref] [PubMed]

T. Adriaenssens, G. J. Ughi, C. Dubois, K. Onsea, D. De Cock, J. Bennett, S. Wiyono, M. Vanhaverbeke, P. Sinnaeve, A. Belmans, J. D’hooge, and W. Desmet, “Automated detection and quantification of clusters of malapposed and uncovered intracoronary stent struts assessed with optical coherence tomography,” Int. J. Cardiovasc. Imaging 30(5), 839–848 (2014).
[Crossref] [PubMed]

A. Wang, S. Nakatani, J. Eggermont, Y. Onuma, H. M. Garcia-Garcia, P. W. Serruys, J. H. C. Reiber, and J. Dijkstra, “Automatic detection of bioresorbable vascular scaffold struts in intravascular optical coherence tomography pullback runs,” Biomed. Opt. Express 5(10), 3589–3602 (2014).
[Crossref] [PubMed]

2013 (2)

G. F. Attizzani and H. G. Bezerra, “Contemporary assessment of stent strut coverage by OCT,” Int. J. Cardiovasc. Imaging 29(1), 23–27 (2013).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

2012 (4)

G. Guagliumi, V. Sirbu, G. Musumeci, R. Gerber, G. Biondi-Zoccai, H. Ikejima, E. Ladich, N. Lortkipanidze, A. Matiashvili, O. Valsecchi, R. Virmani, and G. W. Stone, “Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging,” JACC Cardiovasc. Interv. 5(1), 12–20 (2012).
[Crossref] [PubMed]

H. Lu, M. Gargesha, Z. Wang, D. Chamie, G. F. Attizzani, T. Kanaya, S. Ray, M. A. Costa, A. M. Rollins, H. G. Bezerra, and D. L. Wilson, “Automatic stent detection in intravascular OCT images using bagged decision trees,” Biomed. Opt. Express 3(11), 2809–2824 (2012).
[Crossref] [PubMed]

Z. Wang, D. Chamie, H. G. Bezerra, H. Yamamoto, J. Kanovsky, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Volumetric quantification of fibrous caps using intravascular optical coherence tomography,” Biomed. Opt. Express 3(6), 1413–1426 (2012).
[Crossref] [PubMed]

P. W. Serruys, H. M. Garcia-Garcia, and Y. Onuma, “From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?” Eur. Heart J. 33(1), 16–25 (2012).
[Crossref] [PubMed]

2011 (3)

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

S. Tsantis, G. C. Kagadis, K. Katsanos, D. Karnabatidis, G. Bourantas, and G. C. Nikiforidis, “Automatic vessel lumen segmentation and stent strut detection in intravascular optical coherence tomography,” Med. Phys. 39(1), 503–513 (2011).
[Crossref] [PubMed]

C. Xu, J. M. Schmitt, T. Akasaka, T. Kubo, and K. Huang, “Automatic detection of stent struts with thick neointimal growth in intravascular optical coherence tomography image sequences,” Phys. Med. Biol. 56(20), 6665–6675 (2011).
[Crossref] [PubMed]

2010 (3)

Z. Wang, H. Kyono, H. G. Bezerra, H. Wang, M. Gargesha, C. Alraies, C. Xu, J. M. Schmitt, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Semiautomatic segmentation and quantification of calcified plaques in intracoronary optical coherence tomography images,” J. Biomed. Opt. 15(6), 061711 (2010).
[Crossref] [PubMed]

J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, F. D. Kolodgie, G. L. Kaluza, M. B. Leon, and R. Virmani, “Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix,” Circ. Cardiovasc. Interv. 3(3), 257–266 (2010).
[Crossref] [PubMed]

M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, and R. J. de Winter, “Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study,” Eur. Heart J. 31(9), 1055–1064 (2010).
[Crossref] [PubMed]

2009 (1)

H. G. Bezerra, M. A. Costa, G. Guagliumi, A. M. Rollins, and D. I. Simon, “Intracoronary optical coherence tomography: a comprehensive review clinical and research applications,” JACC Cardiovasc. Interv. 2(11), 1035–1046 (2009).
[Crossref] [PubMed]

2008 (1)

M. E. Pfisterer, “Late Stent Thrombosis After Drug-Eluting Stent Implantation for Acute Myocardial Infarction: A New Red Flag is Raised,” Circulation 118(11), 1117–1119 (2008).
[Crossref] [PubMed]

2007 (2)

T. F. Lüscher, J. Steffel, F. R. Eberli, M. Joner, G. Nakazawa, F. C. Tanner, and R. Virmani, “Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications,” Circulation 115(8), 1051–1058 (2007).
[Crossref] [PubMed]

A. V. Finn, M. Joner, G. Nakazawa, F. Kolodgie, J. Newell, M. C. John, H. K. Gold, and R. Virmani, “Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization,” Circulation 115(18), 2435–2441 (2007).
[Crossref] [PubMed]

2006 (4)

R. Waksman, “Biodegradable stents: they do their job and disappear,” J. Invasive Cardiol. 18(2), 70–74 (2006).
[PubMed]

M. S. Chen, J. M. John, D. P. Chew, D. S. Lee, S. G. Ellis, and D. L. Bhatt, “Bare metal stent restenosis is not a benign clinical entity,” Am. Heart J. 151(6), 1260–1264 (2006).
[Crossref] [PubMed]

M. Joner, A. V. Finn, A. Farb, E. K. Mont, F. D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H. K. Gold, and R. Virmani, “Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk,” J. Am. Coll. Cardiol. 48(1), 193–202 (2006).
[Crossref] [PubMed]

M. Pfisterer, H. P. Brunner-La Rocca, P. T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, C. Kaiser, and BASKET-LATE Investigators, “Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents,” J. Am. Coll. Cardiol. 48(12), 2584–2591 (2006).
[Crossref] [PubMed]

2005 (1)

A. T. L. Ong, E. P. McFadden, E. Regar, P. P. T. de Jaegere, R. T. van Domburg, and P. W. Serruys, “Late angiographic stent thrombosis (LAST) events with drug-eluting stents,” J. Am. Coll. Cardiol. 45(12), 2088–2092 (2005).
[Crossref] [PubMed]

2002 (1)

I.-K. Jang, B. E. Bouma, D.-H. Kang, S.-J. Park, S.-W. Park, K.-B. Seung, K.-B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S. L. Houser, H. T. Aretz, and G. J. Tearney, “Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound,” J. Am. Coll. Cardiol. 39(4), 604–609 (2002).
[Crossref] [PubMed]

1999 (1)

V. N. Vapnik, “An overview of statistical learning theory,” IEEE Trans. Neural Netw. 10(5), 988–999 (1999).
[Crossref] [PubMed]

1998 (1)

C. J. C. Burges, “A Tutorial on Support Vector Machines for Pattern Recognition,” Data Min. Knowl. Discov. 2(2), 121–167 (1998).
[Crossref]

Aboodi, M. S.

J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, F. D. Kolodgie, G. L. Kaluza, M. B. Leon, and R. Virmani, “Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix,” Circ. Cardiovasc. Interv. 3(3), 257–266 (2010).
[Crossref] [PubMed]

Adriaenssens, T.

G. J. Ughi, C. J. Van Dyck, T. Adriaenssens, V. Y. Hoymans, P. Sinnaeve, J.-P. Timmermans, W. Desmet, C. J. Vrints, and J. D’hooge, “Automatic assessment of stent neointimal coverage by intravascular optical coherence tomography,” Eur. Heart J. Cardiovasc. Imaging 15(2), 195–200 (2014).
[Crossref] [PubMed]

T. Adriaenssens, G. J. Ughi, C. Dubois, K. Onsea, D. De Cock, J. Bennett, S. Wiyono, M. Vanhaverbeke, P. Sinnaeve, A. Belmans, J. D’hooge, and W. Desmet, “Automated detection and quantification of clusters of malapposed and uncovered intracoronary stent struts assessed with optical coherence tomography,” Int. J. Cardiovasc. Imaging 30(5), 839–848 (2014).
[Crossref] [PubMed]

Akasaka, T.

C. Xu, J. M. Schmitt, T. Akasaka, T. Kubo, and K. Huang, “Automatic detection of stent struts with thick neointimal growth in intravascular optical coherence tomography image sequences,” Phys. Med. Biol. 56(20), 6665–6675 (2011).
[Crossref] [PubMed]

Alraies, C.

Z. Wang, H. Kyono, H. G. Bezerra, H. Wang, M. Gargesha, C. Alraies, C. Xu, J. M. Schmitt, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Semiautomatic segmentation and quantification of calcified plaques in intracoronary optical coherence tomography images,” J. Biomed. Opt. 15(6), 061711 (2010).
[Crossref] [PubMed]

Amrute, J. M.

J. M. Amrute, L. S. Athanasiou, F. Rikhtegar, J. M. de la Torre Hernández, T. G. Camarero, and E. R. Edelman, “Polymeric endovascular strut and lumen detection algorithm for intracoronary optical coherence tomography images,” J. Biomed. Opt. 23(3), 1–14 (2018).
[Crossref] [PubMed]

Ando, K.

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

Araszkiewicz, A.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Aretz, H. T.

I.-K. Jang, B. E. Bouma, D.-H. Kang, S.-J. Park, S.-W. Park, K.-B. Seung, K.-B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S. L. Houser, H. T. Aretz, and G. J. Tearney, “Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound,” J. Am. Coll. Cardiol. 39(4), 604–609 (2002).
[Crossref] [PubMed]

Athanasiou, L. S.

J. M. Amrute, L. S. Athanasiou, F. Rikhtegar, J. M. de la Torre Hernández, T. G. Camarero, and E. R. Edelman, “Polymeric endovascular strut and lumen detection algorithm for intracoronary optical coherence tomography images,” J. Biomed. Opt. 23(3), 1–14 (2018).
[Crossref] [PubMed]

Attizzani, G. F.

Baan, J.

M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, and R. J. de Winter, “Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study,” Eur. Heart J. 31(9), 1055–1064 (2010).
[Crossref] [PubMed]

Bader, F.

M. Pfisterer, H. P. Brunner-La Rocca, P. T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, C. Kaiser, and BASKET-LATE Investigators, “Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents,” J. Am. Coll. Cardiol. 48(12), 2584–2591 (2006).
[Crossref] [PubMed]

Baumbach, A.

B. Chevalier, Y. Onuma, A. J. van Boven, J. J. Piek, M. Sabaté, S. Helqvist, A. Baumbach, P. C. Smits, R. Kumar, L. Wasungu, and P. W. Serruys, “Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial,” EuroIntervention 12(9), 1102–1107 (2016).
[Crossref] [PubMed]

Beijk, M. A. M.

M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, and R. J. de Winter, “Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study,” Eur. Heart J. 31(9), 1055–1064 (2010).
[Crossref] [PubMed]

Belmans, A.

T. Adriaenssens, G. J. Ughi, C. Dubois, K. Onsea, D. De Cock, J. Bennett, S. Wiyono, M. Vanhaverbeke, P. Sinnaeve, A. Belmans, J. D’hooge, and W. Desmet, “Automated detection and quantification of clusters of malapposed and uncovered intracoronary stent struts assessed with optical coherence tomography,” Int. J. Cardiovasc. Imaging 30(5), 839–848 (2014).
[Crossref] [PubMed]

Bennett, J.

T. Adriaenssens, G. J. Ughi, C. Dubois, K. Onsea, D. De Cock, J. Bennett, S. Wiyono, M. Vanhaverbeke, P. Sinnaeve, A. Belmans, J. D’hooge, and W. Desmet, “Automated detection and quantification of clusters of malapposed and uncovered intracoronary stent struts assessed with optical coherence tomography,” Int. J. Cardiovasc. Imaging 30(5), 839–848 (2014).
[Crossref] [PubMed]

Bertollo, N.

S. McMahon, N. Bertollo, E. D. O. Cearbhaill, J. Salber, L. Pierucci, P. Duffy, T. Dürig, V. Bi, and W. Wang, “Bio-resorbable polymer stents: a review of material progress and prospects,” Prog. Polym. Sci. 83, 79–96 (2018).
[Crossref]

Bezerra, H.

C. Kolluru, D. Prabhu, Y. Gharaibeh, H. Bezerra, G. Guagliumi, and D. Wilson, “Deep neural networks for A-line-based plaque classification in coronary intravascular optical coherence tomography images,” J. Med. Imaging (Bellingham) 5(4), 044504 (2018).
[Crossref] [PubMed]

Bezerra, H. G.

G. F. Attizzani and H. G. Bezerra, “Contemporary assessment of stent strut coverage by OCT,” Int. J. Cardiovasc. Imaging 29(1), 23–27 (2013).
[Crossref] [PubMed]

H. Lu, M. Gargesha, Z. Wang, D. Chamie, G. F. Attizzani, T. Kanaya, S. Ray, M. A. Costa, A. M. Rollins, H. G. Bezerra, and D. L. Wilson, “Automatic stent detection in intravascular OCT images using bagged decision trees,” Biomed. Opt. Express 3(11), 2809–2824 (2012).
[Crossref] [PubMed]

Z. Wang, D. Chamie, H. G. Bezerra, H. Yamamoto, J. Kanovsky, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Volumetric quantification of fibrous caps using intravascular optical coherence tomography,” Biomed. Opt. Express 3(6), 1413–1426 (2012).
[Crossref] [PubMed]

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

Z. Wang, H. Kyono, H. G. Bezerra, H. Wang, M. Gargesha, C. Alraies, C. Xu, J. M. Schmitt, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Semiautomatic segmentation and quantification of calcified plaques in intracoronary optical coherence tomography images,” J. Biomed. Opt. 15(6), 061711 (2010).
[Crossref] [PubMed]

H. G. Bezerra, M. A. Costa, G. Guagliumi, A. M. Rollins, and D. I. Simon, “Intracoronary optical coherence tomography: a comprehensive review clinical and research applications,” JACC Cardiovasc. Interv. 2(11), 1035–1046 (2009).
[Crossref] [PubMed]

R. Shalev, H. G. Bezerra, S. Ray, D. Prabhu, and D. L. Wilson, “Classification of calcium in intravascular OCT images for the purpose of intervention planning,” Proc SPIE Int Soc Opt Eng9786, (2016).

D. Prabhu, E. Mehanna, M. Gargesha, D. Wen, E. Brandt, N. S. van Ditzhuijzen, D. Chamie, H. Yamamoto, Y. Fujino, A. Farmazilian, J. Patel, M. Costa, H. G. Bezerra, and D. L. Wilson, “3D registration of intravascular optical coherence tomography and cryo-image volumes for microscopic-resolution validation,” Proc SPIE Int Soc Opt Eng9788, (2016).

Bezerra, Y.

M. W. Zhao Wang, G. C. Jenkins, H. G. Linderman, Y. Bezerra, M. A. Fujino, D. L. Costa, Wilson, and A. M. Rollins, “3-D Stent Detection in Intravascular OCT Using a Bayesian Network and Graph Search,” IEEE Trans. Med. Imaging 34(7), 1549–1561 (2015).
[Crossref] [PubMed]

Bhatt, D. L.

M. S. Chen, J. M. John, D. P. Chew, D. S. Lee, S. G. Ellis, and D. L. Bhatt, “Bare metal stent restenosis is not a benign clinical entity,” Am. Heart J. 151(6), 1260–1264 (2006).
[Crossref] [PubMed]

Bi, V.

S. McMahon, N. Bertollo, E. D. O. Cearbhaill, J. Salber, L. Pierucci, P. Duffy, T. Dürig, V. Bi, and W. Wang, “Bio-resorbable polymer stents: a review of material progress and prospects,” Prog. Polym. Sci. 83, 79–96 (2018).
[Crossref]

Biondi-Zoccai, G.

G. Guagliumi, V. Sirbu, G. Musumeci, R. Gerber, G. Biondi-Zoccai, H. Ikejima, E. Ladich, N. Lortkipanidze, A. Matiashvili, O. Valsecchi, R. Virmani, and G. W. Stone, “Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging,” JACC Cardiovasc. Interv. 5(1), 12–20 (2012).
[Crossref] [PubMed]

Bouma, B. E.

I.-K. Jang, B. E. Bouma, D.-H. Kang, S.-J. Park, S.-W. Park, K.-B. Seung, K.-B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S. L. Houser, H. T. Aretz, and G. J. Tearney, “Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound,” J. Am. Coll. Cardiol. 39(4), 604–609 (2002).
[Crossref] [PubMed]

Bourantas, G.

S. Tsantis, G. C. Kagadis, K. Katsanos, D. Karnabatidis, G. Bourantas, and G. C. Nikiforidis, “Automatic vessel lumen segmentation and stent strut detection in intravascular optical coherence tomography,” Med. Phys. 39(1), 503–513 (2011).
[Crossref] [PubMed]

Brandt, E.

D. Prabhu, E. Mehanna, M. Gargesha, D. Wen, E. Brandt, N. S. van Ditzhuijzen, D. Chamie, H. Yamamoto, Y. Fujino, A. Farmazilian, J. Patel, M. Costa, H. G. Bezerra, and D. L. Wilson, “3D registration of intravascular optical coherence tomography and cryo-image volumes for microscopic-resolution validation,” Proc SPIE Int Soc Opt Eng9788, (2016).

Brunner-La Rocca, H. P.

M. Pfisterer, H. P. Brunner-La Rocca, P. T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, C. Kaiser, and BASKET-LATE Investigators, “Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents,” J. Am. Coll. Cardiol. 48(12), 2584–2591 (2006).
[Crossref] [PubMed]

Burges, C. J. C.

C. J. C. Burges, “A Tutorial on Support Vector Machines for Pattern Recognition,” Data Min. Knowl. Discov. 2(2), 121–167 (1998).
[Crossref]

Buser, P. T.

M. Pfisterer, H. P. Brunner-La Rocca, P. T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, C. Kaiser, and BASKET-LATE Investigators, “Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents,” J. Am. Coll. Cardiol. 48(12), 2584–2591 (2006).
[Crossref] [PubMed]

Camarero, T. G.

J. M. Amrute, L. S. Athanasiou, F. Rikhtegar, J. M. de la Torre Hernández, T. G. Camarero, and E. R. Edelman, “Polymeric endovascular strut and lumen detection algorithm for intracoronary optical coherence tomography images,” J. Biomed. Opt. 23(3), 1–14 (2018).
[Crossref] [PubMed]

Campo, G.

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

Capodanno, D.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Capranzano, P.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Caramanno, G.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Carrié, D.

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

Cearbhaill, E. D. O.

S. McMahon, N. Bertollo, E. D. O. Cearbhaill, J. Salber, L. Pierucci, P. Duffy, T. Dürig, V. Bi, and W. Wang, “Bio-resorbable polymer stents: a review of material progress and prospects,” Prog. Polym. Sci. 83, 79–96 (2018).
[Crossref]

Cequier, A.

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

Chamie, D.

Chen, M. S.

M. S. Chen, J. M. John, D. P. Chew, D. S. Lee, S. G. Ellis, and D. L. Bhatt, “Bare metal stent restenosis is not a benign clinical entity,” Am. Heart J. 151(6), 1260–1264 (2006).
[Crossref] [PubMed]

Chevalier, B.

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

B. Chevalier, Y. Onuma, A. J. van Boven, J. J. Piek, M. Sabaté, S. Helqvist, A. Baumbach, P. C. Smits, R. Kumar, L. Wasungu, and P. W. Serruys, “Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial,” EuroIntervention 12(9), 1102–1107 (2016).
[Crossref] [PubMed]

Chew, D. P.

M. S. Chen, J. M. John, D. P. Chew, D. S. Lee, S. G. Ellis, and D. L. Bhatt, “Bare metal stent restenosis is not a benign clinical entity,” Am. Heart J. 151(6), 1260–1264 (2006).
[Crossref] [PubMed]

Choi, K.-B.

I.-K. Jang, B. E. Bouma, D.-H. Kang, S.-J. Park, S.-W. Park, K.-B. Seung, K.-B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S. L. Houser, H. T. Aretz, and G. J. Tearney, “Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound,” J. Am. Coll. Cardiol. 39(4), 604–609 (2002).
[Crossref] [PubMed]

Colombo, A.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Costa, D. L.

M. W. Zhao Wang, G. C. Jenkins, H. G. Linderman, Y. Bezerra, M. A. Fujino, D. L. Costa, Wilson, and A. M. Rollins, “3-D Stent Detection in Intravascular OCT Using a Bayesian Network and Graph Search,” IEEE Trans. Med. Imaging 34(7), 1549–1561 (2015).
[Crossref] [PubMed]

Costa, M.

D. Prabhu, E. Mehanna, M. Gargesha, D. Wen, E. Brandt, N. S. van Ditzhuijzen, D. Chamie, H. Yamamoto, Y. Fujino, A. Farmazilian, J. Patel, M. Costa, H. G. Bezerra, and D. L. Wilson, “3D registration of intravascular optical coherence tomography and cryo-image volumes for microscopic-resolution validation,” Proc SPIE Int Soc Opt Eng9788, (2016).

Costa, M. A.

Z. Wang, D. Chamie, H. G. Bezerra, H. Yamamoto, J. Kanovsky, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Volumetric quantification of fibrous caps using intravascular optical coherence tomography,” Biomed. Opt. Express 3(6), 1413–1426 (2012).
[Crossref] [PubMed]

H. Lu, M. Gargesha, Z. Wang, D. Chamie, G. F. Attizzani, T. Kanaya, S. Ray, M. A. Costa, A. M. Rollins, H. G. Bezerra, and D. L. Wilson, “Automatic stent detection in intravascular OCT images using bagged decision trees,” Biomed. Opt. Express 3(11), 2809–2824 (2012).
[Crossref] [PubMed]

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

Z. Wang, H. Kyono, H. G. Bezerra, H. Wang, M. Gargesha, C. Alraies, C. Xu, J. M. Schmitt, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Semiautomatic segmentation and quantification of calcified plaques in intracoronary optical coherence tomography images,” J. Biomed. Opt. 15(6), 061711 (2010).
[Crossref] [PubMed]

H. G. Bezerra, M. A. Costa, G. Guagliumi, A. M. Rollins, and D. I. Simon, “Intracoronary optical coherence tomography: a comprehensive review clinical and research applications,” JACC Cardiovasc. Interv. 2(11), 1035–1046 (2009).
[Crossref] [PubMed]

Cristea, E.

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

D’hooge, J.

G. J. Ughi, C. J. Van Dyck, T. Adriaenssens, V. Y. Hoymans, P. Sinnaeve, J.-P. Timmermans, W. Desmet, C. J. Vrints, and J. D’hooge, “Automatic assessment of stent neointimal coverage by intravascular optical coherence tomography,” Eur. Heart J. Cardiovasc. Imaging 15(2), 195–200 (2014).
[Crossref] [PubMed]

T. Adriaenssens, G. J. Ughi, C. Dubois, K. Onsea, D. De Cock, J. Bennett, S. Wiyono, M. Vanhaverbeke, P. Sinnaeve, A. Belmans, J. D’hooge, and W. Desmet, “Automated detection and quantification of clusters of malapposed and uncovered intracoronary stent struts assessed with optical coherence tomography,” Int. J. Cardiovasc. Imaging 30(5), 839–848 (2014).
[Crossref] [PubMed]

Daemen, J.

C. M. Felix, J. M. Fam, R. Diletti, Y. Ishibashi, A. Karanasos, B. R. C. Everaert, N. M. D. A. van Mieghem, J. Daemen, P. P. T. de Jaegere, F. Zijlstra, E. S. Regar, Y. Onuma, and R.-J. M. van Geuns, “Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry,” JACC Cardiovasc. Interv. 9(16), 1652–1663 (2016).
[Crossref] [PubMed]

J. M. Fam, C. Felix, R. J. van Geuns, Y. Onuma, N. M. Van Mieghem, A. Karanasos, J. van der Sijde, M. De Paolis, E. Regar, M. Valgimigli, J. Daemen, P. de Jaegere, F. Zijlstra, and R. Diletti, “Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study,” EuroIntervention 12(1), 30–37 (2016).
[Crossref] [PubMed]

De Cock, D.

T. Adriaenssens, G. J. Ughi, C. Dubois, K. Onsea, D. De Cock, J. Bennett, S. Wiyono, M. Vanhaverbeke, P. Sinnaeve, A. Belmans, J. D’hooge, and W. Desmet, “Automated detection and quantification of clusters of malapposed and uncovered intracoronary stent struts assessed with optical coherence tomography,” Int. J. Cardiovasc. Imaging 30(5), 839–848 (2014).
[Crossref] [PubMed]

de Jaegere, P.

J. M. Fam, C. Felix, R. J. van Geuns, Y. Onuma, N. M. Van Mieghem, A. Karanasos, J. van der Sijde, M. De Paolis, E. Regar, M. Valgimigli, J. Daemen, P. de Jaegere, F. Zijlstra, and R. Diletti, “Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study,” EuroIntervention 12(1), 30–37 (2016).
[Crossref] [PubMed]

de Jaegere, P. P. T.

C. M. Felix, J. M. Fam, R. Diletti, Y. Ishibashi, A. Karanasos, B. R. C. Everaert, N. M. D. A. van Mieghem, J. Daemen, P. P. T. de Jaegere, F. Zijlstra, E. S. Regar, Y. Onuma, and R.-J. M. van Geuns, “Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry,” JACC Cardiovasc. Interv. 9(16), 1652–1663 (2016).
[Crossref] [PubMed]

A. T. L. Ong, E. P. McFadden, E. Regar, P. P. T. de Jaegere, R. T. van Domburg, and P. W. Serruys, “Late angiographic stent thrombosis (LAST) events with drug-eluting stents,” J. Am. Coll. Cardiol. 45(12), 2088–2092 (2005).
[Crossref] [PubMed]

de la Torre Hernández, J. M.

J. M. Amrute, L. S. Athanasiou, F. Rikhtegar, J. M. de la Torre Hernández, T. G. Camarero, and E. R. Edelman, “Polymeric endovascular strut and lumen detection algorithm for intracoronary optical coherence tomography images,” J. Biomed. Opt. 23(3), 1–14 (2018).
[Crossref] [PubMed]

De Paolis, M.

J. M. Fam, C. Felix, R. J. van Geuns, Y. Onuma, N. M. Van Mieghem, A. Karanasos, J. van der Sijde, M. De Paolis, E. Regar, M. Valgimigli, J. Daemen, P. de Jaegere, F. Zijlstra, and R. Diletti, “Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study,” EuroIntervention 12(1), 30–37 (2016).
[Crossref] [PubMed]

de Sousa Almeida, M.

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

de Winter, R. J.

M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, and R. J. de Winter, “Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study,” Eur. Heart J. 31(9), 1055–1064 (2010).
[Crossref] [PubMed]

Dekker, N.

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

Desmet, W.

G. J. Ughi, C. J. Van Dyck, T. Adriaenssens, V. Y. Hoymans, P. Sinnaeve, J.-P. Timmermans, W. Desmet, C. J. Vrints, and J. D’hooge, “Automatic assessment of stent neointimal coverage by intravascular optical coherence tomography,” Eur. Heart J. Cardiovasc. Imaging 15(2), 195–200 (2014).
[Crossref] [PubMed]

T. Adriaenssens, G. J. Ughi, C. Dubois, K. Onsea, D. De Cock, J. Bennett, S. Wiyono, M. Vanhaverbeke, P. Sinnaeve, A. Belmans, J. D’hooge, and W. Desmet, “Automated detection and quantification of clusters of malapposed and uncovered intracoronary stent struts assessed with optical coherence tomography,” Int. J. Cardiovasc. Imaging 30(5), 839–848 (2014).
[Crossref] [PubMed]

Di Mario, C.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Dijkstra, J.

A. Wang, S. Nakatani, J. Eggermont, Y. Onuma, H. M. Garcia-Garcia, P. W. Serruys, J. H. C. Reiber, and J. Dijkstra, “Automatic detection of bioresorbable vascular scaffold struts in intravascular optical coherence tomography pullback runs,” Biomed. Opt. Express 5(10), 3589–3602 (2014).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

Diletti, R.

J. M. Fam, C. Felix, R. J. van Geuns, Y. Onuma, N. M. Van Mieghem, A. Karanasos, J. van der Sijde, M. De Paolis, E. Regar, M. Valgimigli, J. Daemen, P. de Jaegere, F. Zijlstra, and R. Diletti, “Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study,” EuroIntervention 12(1), 30–37 (2016).
[Crossref] [PubMed]

C. M. Felix, J. M. Fam, R. Diletti, Y. Ishibashi, A. Karanasos, B. R. C. Everaert, N. M. D. A. van Mieghem, J. Daemen, P. P. T. de Jaegere, F. Zijlstra, E. S. Regar, Y. Onuma, and R.-J. M. van Geuns, “Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry,” JACC Cardiovasc. Interv. 9(16), 1652–1663 (2016).
[Crossref] [PubMed]

Dominici, M.

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

Dressler, O.

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

Dubois, C.

T. Adriaenssens, G. J. Ughi, C. Dubois, K. Onsea, D. De Cock, J. Bennett, S. Wiyono, M. Vanhaverbeke, P. Sinnaeve, A. Belmans, J. D’hooge, and W. Desmet, “Automated detection and quantification of clusters of malapposed and uncovered intracoronary stent struts assessed with optical coherence tomography,” Int. J. Cardiovasc. Imaging 30(5), 839–848 (2014).
[Crossref] [PubMed]

Dudek, D.

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

Duffy, P.

S. McMahon, N. Bertollo, E. D. O. Cearbhaill, J. Salber, L. Pierucci, P. Duffy, T. Dürig, V. Bi, and W. Wang, “Bio-resorbable polymer stents: a review of material progress and prospects,” Prog. Polym. Sci. 83, 79–96 (2018).
[Crossref]

Dürig, T.

S. McMahon, N. Bertollo, E. D. O. Cearbhaill, J. Salber, L. Pierucci, P. Duffy, T. Dürig, V. Bi, and W. Wang, “Bio-resorbable polymer stents: a review of material progress and prospects,” Prog. Polym. Sci. 83, 79–96 (2018).
[Crossref]

Eberli, F. R.

T. F. Lüscher, J. Steffel, F. R. Eberli, M. Joner, G. Nakazawa, F. C. Tanner, and R. Virmani, “Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications,” Circulation 115(8), 1051–1058 (2007).
[Crossref] [PubMed]

Edelman, E. R.

J. M. Amrute, L. S. Athanasiou, F. Rikhtegar, J. M. de la Torre Hernández, T. G. Camarero, and E. R. Edelman, “Polymeric endovascular strut and lumen detection algorithm for intracoronary optical coherence tomography images,” J. Biomed. Opt. 23(3), 1–14 (2018).
[Crossref] [PubMed]

Eggermont, J.

A. Wang, S. Nakatani, J. Eggermont, Y. Onuma, H. M. Garcia-Garcia, P. W. Serruys, J. H. C. Reiber, and J. Dijkstra, “Automatic detection of bioresorbable vascular scaffold struts in intravascular optical coherence tomography pullback runs,” Biomed. Opt. Express 5(10), 3589–3602 (2014).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

Ellis, S. G.

M. S. Chen, J. M. John, D. P. Chew, D. S. Lee, S. G. Ellis, and D. L. Bhatt, “Bare metal stent restenosis is not a benign clinical entity,” Am. Heart J. 151(6), 1260–1264 (2006).
[Crossref] [PubMed]

Everaert, B. R. C.

C. M. Felix, J. M. Fam, R. Diletti, Y. Ishibashi, A. Karanasos, B. R. C. Everaert, N. M. D. A. van Mieghem, J. Daemen, P. P. T. de Jaegere, F. Zijlstra, E. S. Regar, Y. Onuma, and R.-J. M. van Geuns, “Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry,” JACC Cardiovasc. Interv. 9(16), 1652–1663 (2016).
[Crossref] [PubMed]

Fam, J. M.

C. M. Felix, J. M. Fam, R. Diletti, Y. Ishibashi, A. Karanasos, B. R. C. Everaert, N. M. D. A. van Mieghem, J. Daemen, P. P. T. de Jaegere, F. Zijlstra, E. S. Regar, Y. Onuma, and R.-J. M. van Geuns, “Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry,” JACC Cardiovasc. Interv. 9(16), 1652–1663 (2016).
[Crossref] [PubMed]

J. M. Fam, C. Felix, R. J. van Geuns, Y. Onuma, N. M. Van Mieghem, A. Karanasos, J. van der Sijde, M. De Paolis, E. Regar, M. Valgimigli, J. Daemen, P. de Jaegere, F. Zijlstra, and R. Diletti, “Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study,” EuroIntervention 12(1), 30–37 (2016).
[Crossref] [PubMed]

Farb, A.

M. Joner, A. V. Finn, A. Farb, E. K. Mont, F. D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H. K. Gold, and R. Virmani, “Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk,” J. Am. Coll. Cardiol. 48(1), 193–202 (2006).
[Crossref] [PubMed]

Farmazilian, A.

D. Prabhu, E. Mehanna, M. Gargesha, D. Wen, E. Brandt, N. S. van Ditzhuijzen, D. Chamie, H. Yamamoto, Y. Fujino, A. Farmazilian, J. Patel, M. Costa, H. G. Bezerra, and D. L. Wilson, “3D registration of intravascular optical coherence tomography and cryo-image volumes for microscopic-resolution validation,” Proc SPIE Int Soc Opt Eng9788, (2016).

Felix, C.

J. M. Fam, C. Felix, R. J. van Geuns, Y. Onuma, N. M. Van Mieghem, A. Karanasos, J. van der Sijde, M. De Paolis, E. Regar, M. Valgimigli, J. Daemen, P. de Jaegere, F. Zijlstra, and R. Diletti, “Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study,” EuroIntervention 12(1), 30–37 (2016).
[Crossref] [PubMed]

Felix, C. M.

C. M. Felix, J. M. Fam, R. Diletti, Y. Ishibashi, A. Karanasos, B. R. C. Everaert, N. M. D. A. van Mieghem, J. Daemen, P. P. T. de Jaegere, F. Zijlstra, E. S. Regar, Y. Onuma, and R.-J. M. van Geuns, “Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry,” JACC Cardiovasc. Interv. 9(16), 1652–1663 (2016).
[Crossref] [PubMed]

Finn, A. V.

A. V. Finn, M. Joner, G. Nakazawa, F. Kolodgie, J. Newell, M. C. John, H. K. Gold, and R. Virmani, “Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization,” Circulation 115(18), 2435–2441 (2007).
[Crossref] [PubMed]

M. Joner, A. V. Finn, A. Farb, E. K. Mont, F. D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H. K. Gold, and R. Virmani, “Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk,” J. Am. Coll. Cardiol. 48(1), 193–202 (2006).
[Crossref] [PubMed]

Fujino, M. A.

M. W. Zhao Wang, G. C. Jenkins, H. G. Linderman, Y. Bezerra, M. A. Fujino, D. L. Costa, Wilson, and A. M. Rollins, “3-D Stent Detection in Intravascular OCT Using a Bayesian Network and Graph Search,” IEEE Trans. Med. Imaging 34(7), 1549–1561 (2015).
[Crossref] [PubMed]

Fujino, Y.

D. Prabhu, E. Mehanna, M. Gargesha, D. Wen, E. Brandt, N. S. van Ditzhuijzen, D. Chamie, H. Yamamoto, Y. Fujino, A. Farmazilian, J. Patel, M. Costa, H. G. Bezerra, and D. L. Wilson, “3D registration of intravascular optical coherence tomography and cryo-image volumes for microscopic-resolution validation,” Proc SPIE Int Soc Opt Eng9788, (2016).

Furuya, J.

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

Garcia-Garcia, H. M.

A. Wang, S. Nakatani, J. Eggermont, Y. Onuma, H. M. Garcia-Garcia, P. W. Serruys, J. H. C. Reiber, and J. Dijkstra, “Automatic detection of bioresorbable vascular scaffold struts in intravascular optical coherence tomography pullback runs,” Biomed. Opt. Express 5(10), 3589–3602 (2014).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

P. W. Serruys, H. M. Garcia-Garcia, and Y. Onuma, “From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?” Eur. Heart J. 33(1), 16–25 (2012).
[Crossref] [PubMed]

Gargesha, M.

H. Lu, M. Gargesha, Z. Wang, D. Chamie, G. F. Attizzani, T. Kanaya, S. Ray, M. A. Costa, A. M. Rollins, H. G. Bezerra, and D. L. Wilson, “Automatic stent detection in intravascular OCT images using bagged decision trees,” Biomed. Opt. Express 3(11), 2809–2824 (2012).
[Crossref] [PubMed]

Z. Wang, H. Kyono, H. G. Bezerra, H. Wang, M. Gargesha, C. Alraies, C. Xu, J. M. Schmitt, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Semiautomatic segmentation and quantification of calcified plaques in intracoronary optical coherence tomography images,” J. Biomed. Opt. 15(6), 061711 (2010).
[Crossref] [PubMed]

D. Prabhu, E. Mehanna, M. Gargesha, D. Wen, E. Brandt, N. S. van Ditzhuijzen, D. Chamie, H. Yamamoto, Y. Fujino, A. Farmazilian, J. Patel, M. Costa, H. G. Bezerra, and D. L. Wilson, “3D registration of intravascular optical coherence tomography and cryo-image volumes for microscopic-resolution validation,” Proc SPIE Int Soc Opt Eng9788, (2016).

Geraci, S.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Gerber, R.

G. Guagliumi, V. Sirbu, G. Musumeci, R. Gerber, G. Biondi-Zoccai, H. Ikejima, E. Ladich, N. Lortkipanidze, A. Matiashvili, O. Valsecchi, R. Virmani, and G. W. Stone, “Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging,” JACC Cardiovasc. Interv. 5(1), 12–20 (2012).
[Crossref] [PubMed]

Gharaibeh, Y.

C. Kolluru, D. Prabhu, Y. Gharaibeh, H. Bezerra, G. Guagliumi, and D. Wilson, “Deep neural networks for A-line-based plaque classification in coronary intravascular optical coherence tomography images,” J. Med. Imaging (Bellingham) 5(4), 044504 (2018).
[Crossref] [PubMed]

C. Kolluru, D. Prabhu, Y. Gharaibeh, H. Wu, and D. L. Wilson, “Voxel-based plaque classification in coronary intravascular optical coherence tomography images using decision trees,” Proc SPIE Int Soc Opt Eng10575, (2018).
[Crossref]

Gold, H. K.

A. V. Finn, M. Joner, G. Nakazawa, F. Kolodgie, J. Newell, M. C. John, H. K. Gold, and R. Virmani, “Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization,” Circulation 115(18), 2435–2441 (2007).
[Crossref] [PubMed]

M. Joner, A. V. Finn, A. Farb, E. K. Mont, F. D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H. K. Gold, and R. Virmani, “Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk,” J. Am. Coll. Cardiol. 48(1), 193–202 (2006).
[Crossref] [PubMed]

Gori, T.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Granada, J. F.

J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, F. D. Kolodgie, G. L. Kaluza, M. B. Leon, and R. Virmani, “Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix,” Circ. Cardiovasc. Interv. 3(3), 257–266 (2010).
[Crossref] [PubMed]

Guagliumi, G.

C. Kolluru, D. Prabhu, Y. Gharaibeh, H. Bezerra, G. Guagliumi, and D. Wilson, “Deep neural networks for A-line-based plaque classification in coronary intravascular optical coherence tomography images,” J. Med. Imaging (Bellingham) 5(4), 044504 (2018).
[Crossref] [PubMed]

G. Guagliumi, V. Sirbu, G. Musumeci, R. Gerber, G. Biondi-Zoccai, H. Ikejima, E. Ladich, N. Lortkipanidze, A. Matiashvili, O. Valsecchi, R. Virmani, and G. W. Stone, “Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging,” JACC Cardiovasc. Interv. 5(1), 12–20 (2012).
[Crossref] [PubMed]

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

H. G. Bezerra, M. A. Costa, G. Guagliumi, A. M. Rollins, and D. I. Simon, “Intracoronary optical coherence tomography: a comprehensive review clinical and research applications,” JACC Cardiovasc. Interv. 2(11), 1035–1046 (2009).
[Crossref] [PubMed]

Haude, M.

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

Helqvist, S.

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

B. Chevalier, Y. Onuma, A. J. van Boven, J. J. Piek, M. Sabaté, S. Helqvist, A. Baumbach, P. C. Smits, R. Kumar, L. Wasungu, and P. W. Serruys, “Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial,” EuroIntervention 12(9), 1102–1107 (2016).
[Crossref] [PubMed]

Henriques, J. P. S.

M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, and R. J. de Winter, “Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study,” Eur. Heart J. 31(9), 1055–1064 (2010).
[Crossref] [PubMed]

Houser, S. L.

I.-K. Jang, B. E. Bouma, D.-H. Kang, S.-J. Park, S.-W. Park, K.-B. Seung, K.-B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S. L. Houser, H. T. Aretz, and G. J. Tearney, “Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound,” J. Am. Coll. Cardiol. 39(4), 604–609 (2002).
[Crossref] [PubMed]

Hoymans, V. Y.

G. J. Ughi, C. J. Van Dyck, T. Adriaenssens, V. Y. Hoymans, P. Sinnaeve, J.-P. Timmermans, W. Desmet, C. J. Vrints, and J. D’hooge, “Automatic assessment of stent neointimal coverage by intravascular optical coherence tomography,” Eur. Heart J. Cardiovasc. Imaging 15(2), 195–200 (2014).
[Crossref] [PubMed]

Huang, K.

C. Xu, J. M. Schmitt, T. Akasaka, T. Kubo, and K. Huang, “Automatic detection of stent struts with thick neointimal growth in intravascular optical coherence tomography image sequences,” Phys. Med. Biol. 56(20), 6665–6675 (2011).
[Crossref] [PubMed]

Hunziker, P.

M. Pfisterer, H. P. Brunner-La Rocca, P. T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, C. Kaiser, and BASKET-LATE Investigators, “Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents,” J. Am. Coll. Cardiol. 48(12), 2584–2591 (2006).
[Crossref] [PubMed]

Igarashi, K.

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

Ikejima, H.

G. Guagliumi, V. Sirbu, G. Musumeci, R. Gerber, G. Biondi-Zoccai, H. Ikejima, E. Ladich, N. Lortkipanidze, A. Matiashvili, O. Valsecchi, R. Virmani, and G. W. Stone, “Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging,” JACC Cardiovasc. Interv. 5(1), 12–20 (2012).
[Crossref] [PubMed]

Inami, S.

J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, F. D. Kolodgie, G. L. Kaluza, M. B. Leon, and R. Virmani, “Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix,” Circ. Cardiovasc. Interv. 3(3), 257–266 (2010).
[Crossref] [PubMed]

Iñiguez, A.

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

Ishibashi, Y.

C. M. Felix, J. M. Fam, R. Diletti, Y. Ishibashi, A. Karanasos, B. R. C. Everaert, N. M. D. A. van Mieghem, J. Daemen, P. P. T. de Jaegere, F. Zijlstra, E. S. Regar, Y. Onuma, and R.-J. M. van Geuns, “Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry,” JACC Cardiovasc. Interv. 9(16), 1652–1663 (2016).
[Crossref] [PubMed]

Y. Ishibashi, S. Nakatani, and Y. Onuma, “Definite and probable bioresorbable scaffold thrombosis in stable and ACS patients,” EuroIntervention 11(3), e1–e2 (2015).
[Crossref] [PubMed]

Jang, I.-K.

I.-K. Jang, B. E. Bouma, D.-H. Kang, S.-J. Park, S.-W. Park, K.-B. Seung, K.-B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S. L. Houser, H. T. Aretz, and G. J. Tearney, “Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound,” J. Am. Coll. Cardiol. 39(4), 604–609 (2002).
[Crossref] [PubMed]

Jeger, R.

M. Pfisterer, H. P. Brunner-La Rocca, P. T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, C. Kaiser, and BASKET-LATE Investigators, “Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents,” J. Am. Coll. Cardiol. 48(12), 2584–2591 (2006).
[Crossref] [PubMed]

Jenkins, G. C.

M. W. Zhao Wang, G. C. Jenkins, H. G. Linderman, Y. Bezerra, M. A. Fujino, D. L. Costa, Wilson, and A. M. Rollins, “3-D Stent Detection in Intravascular OCT Using a Bayesian Network and Graph Search,” IEEE Trans. Med. Imaging 34(7), 1549–1561 (2015).
[Crossref] [PubMed]

John, J. M.

M. S. Chen, J. M. John, D. P. Chew, D. S. Lee, S. G. Ellis, and D. L. Bhatt, “Bare metal stent restenosis is not a benign clinical entity,” Am. Heart J. 151(6), 1260–1264 (2006).
[Crossref] [PubMed]

John, M. C.

A. V. Finn, M. Joner, G. Nakazawa, F. Kolodgie, J. Newell, M. C. John, H. K. Gold, and R. Virmani, “Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization,” Circulation 115(18), 2435–2441 (2007).
[Crossref] [PubMed]

Joner, M.

A. V. Finn, M. Joner, G. Nakazawa, F. Kolodgie, J. Newell, M. C. John, H. K. Gold, and R. Virmani, “Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization,” Circulation 115(18), 2435–2441 (2007).
[Crossref] [PubMed]

T. F. Lüscher, J. Steffel, F. R. Eberli, M. Joner, G. Nakazawa, F. C. Tanner, and R. Virmani, “Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications,” Circulation 115(8), 1051–1058 (2007).
[Crossref] [PubMed]

M. Joner, A. V. Finn, A. Farb, E. K. Mont, F. D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H. K. Gold, and R. Virmani, “Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk,” J. Am. Coll. Cardiol. 48(1), 193–202 (2006).
[Crossref] [PubMed]

Kagadis, G. C.

S. Tsantis, G. C. Kagadis, K. Katsanos, D. Karnabatidis, G. Bourantas, and G. C. Nikiforidis, “Automatic vessel lumen segmentation and stent strut detection in intravascular optical coherence tomography,” Med. Phys. 39(1), 503–513 (2011).
[Crossref] [PubMed]

Kaiser, C.

M. Pfisterer, H. P. Brunner-La Rocca, P. T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, C. Kaiser, and BASKET-LATE Investigators, “Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents,” J. Am. Coll. Cardiol. 48(12), 2584–2591 (2006).
[Crossref] [PubMed]

Kaluza, G. L.

J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, F. D. Kolodgie, G. L. Kaluza, M. B. Leon, and R. Virmani, “Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix,” Circ. Cardiovasc. Interv. 3(3), 257–266 (2010).
[Crossref] [PubMed]

Kanaya, T.

Kang, D.-H.

I.-K. Jang, B. E. Bouma, D.-H. Kang, S.-J. Park, S.-W. Park, K.-B. Seung, K.-B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S. L. Houser, H. T. Aretz, and G. J. Tearney, “Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound,” J. Am. Coll. Cardiol. 39(4), 604–609 (2002).
[Crossref] [PubMed]

Kanovsky, J.

Karanasos, A.

C. M. Felix, J. M. Fam, R. Diletti, Y. Ishibashi, A. Karanasos, B. R. C. Everaert, N. M. D. A. van Mieghem, J. Daemen, P. P. T. de Jaegere, F. Zijlstra, E. S. Regar, Y. Onuma, and R.-J. M. van Geuns, “Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry,” JACC Cardiovasc. Interv. 9(16), 1652–1663 (2016).
[Crossref] [PubMed]

J. M. Fam, C. Felix, R. J. van Geuns, Y. Onuma, N. M. Van Mieghem, A. Karanasos, J. van der Sijde, M. De Paolis, E. Regar, M. Valgimigli, J. Daemen, P. de Jaegere, F. Zijlstra, and R. Diletti, “Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study,” EuroIntervention 12(1), 30–37 (2016).
[Crossref] [PubMed]

Karnabatidis, D.

S. Tsantis, G. C. Kagadis, K. Katsanos, D. Karnabatidis, G. Bourantas, and G. C. Nikiforidis, “Automatic vessel lumen segmentation and stent strut detection in intravascular optical coherence tomography,” Med. Phys. 39(1), 503–513 (2011).
[Crossref] [PubMed]

Katsanos, K.

S. Tsantis, G. C. Kagadis, K. Katsanos, D. Karnabatidis, G. Bourantas, and G. C. Nikiforidis, “Automatic vessel lumen segmentation and stent strut detection in intravascular optical coherence tomography,” Med. Phys. 39(1), 503–513 (2011).
[Crossref] [PubMed]

Kim, C.-S.

H. S. Nam, C.-S. Kim, J. J. Lee, J. W. Song, J. W. Kim, and H. Yoo, “Automated detection of vessel lumen and stent struts in intravascular optical coherence tomography to evaluate stent apposition and neointimal coverage,” Med. Phys. 43(4), 1662–1675 (2016).
[Crossref] [PubMed]

Kim, J. W.

H. S. Nam, C.-S. Kim, J. J. Lee, J. W. Song, J. W. Kim, and H. Yoo, “Automated detection of vessel lumen and stent struts in intravascular optical coherence tomography to evaluate stent apposition and neointimal coverage,” Med. Phys. 43(4), 1662–1675 (2016).
[Crossref] [PubMed]

Kimura, T.

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

Klomp, M.

M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, and R. J. de Winter, “Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study,” Eur. Heart J. 31(9), 1055–1064 (2010).
[Crossref] [PubMed]

Koch, K. T.

M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, and R. J. de Winter, “Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study,” Eur. Heart J. 31(9), 1055–1064 (2010).
[Crossref] [PubMed]

Kolluru, C.

C. Kolluru, D. Prabhu, Y. Gharaibeh, H. Bezerra, G. Guagliumi, and D. Wilson, “Deep neural networks for A-line-based plaque classification in coronary intravascular optical coherence tomography images,” J. Med. Imaging (Bellingham) 5(4), 044504 (2018).
[Crossref] [PubMed]

C. Kolluru, D. Prabhu, Y. Gharaibeh, H. Wu, and D. L. Wilson, “Voxel-based plaque classification in coronary intravascular optical coherence tomography images using decision trees,” Proc SPIE Int Soc Opt Eng10575, (2018).
[Crossref]

Kolodgie, F.

A. V. Finn, M. Joner, G. Nakazawa, F. Kolodgie, J. Newell, M. C. John, H. K. Gold, and R. Virmani, “Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization,” Circulation 115(18), 2435–2441 (2007).
[Crossref] [PubMed]

Kolodgie, F. D.

J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, F. D. Kolodgie, G. L. Kaluza, M. B. Leon, and R. Virmani, “Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix,” Circ. Cardiovasc. Interv. 3(3), 257–266 (2010).
[Crossref] [PubMed]

M. Joner, A. V. Finn, A. Farb, E. K. Mont, F. D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H. K. Gold, and R. Virmani, “Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk,” J. Am. Coll. Cardiol. 48(1), 193–202 (2006).
[Crossref] [PubMed]

Kozuma, K.

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

Kubo, T.

C. Xu, J. M. Schmitt, T. Akasaka, T. Kubo, and K. Huang, “Automatic detection of stent struts with thick neointimal growth in intravascular optical coherence tomography image sequences,” Phys. Med. Biol. 56(20), 6665–6675 (2011).
[Crossref] [PubMed]

Kumar, R.

B. Chevalier, Y. Onuma, A. J. van Boven, J. J. Piek, M. Sabaté, S. Helqvist, A. Baumbach, P. C. Smits, R. Kumar, L. Wasungu, and P. W. Serruys, “Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial,” EuroIntervention 12(9), 1102–1107 (2016).
[Crossref] [PubMed]

Kusano, H.

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

Kutys, R.

M. Joner, A. V. Finn, A. Farb, E. K. Mont, F. D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H. K. Gold, and R. Virmani, “Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk,” J. Am. Coll. Cardiol. 48(1), 193–202 (2006).
[Crossref] [PubMed]

Kyono, H.

Z. Wang, H. Kyono, H. G. Bezerra, H. Wang, M. Gargesha, C. Alraies, C. Xu, J. M. Schmitt, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Semiautomatic segmentation and quantification of calcified plaques in intracoronary optical coherence tomography images,” J. Biomed. Opt. 15(6), 061711 (2010).
[Crossref] [PubMed]

Ladich, E.

G. Guagliumi, V. Sirbu, G. Musumeci, R. Gerber, G. Biondi-Zoccai, H. Ikejima, E. Ladich, N. Lortkipanidze, A. Matiashvili, O. Valsecchi, R. Virmani, and G. W. Stone, “Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging,” JACC Cardiovasc. Interv. 5(1), 12–20 (2012).
[Crossref] [PubMed]

M. Joner, A. V. Finn, A. Farb, E. K. Mont, F. D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H. K. Gold, and R. Virmani, “Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk,” J. Am. Coll. Cardiol. 48(1), 193–202 (2006).
[Crossref] [PubMed]

Lansky, A. J.

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

Latib, A.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Lee, D. S.

M. S. Chen, J. M. John, D. P. Chew, D. S. Lee, S. G. Ellis, and D. L. Bhatt, “Bare metal stent restenosis is not a benign clinical entity,” Am. Heart J. 151(6), 1260–1264 (2006).
[Crossref] [PubMed]

Lee, J. J.

H. S. Nam, C.-S. Kim, J. J. Lee, J. W. Song, J. W. Kim, and H. Yoo, “Automated detection of vessel lumen and stent struts in intravascular optical coherence tomography to evaluate stent apposition and neointimal coverage,” Med. Phys. 43(4), 1662–1675 (2016).
[Crossref] [PubMed]

Leon, M. B.

J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, F. D. Kolodgie, G. L. Kaluza, M. B. Leon, and R. Virmani, “Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix,” Circ. Cardiovasc. Interv. 3(3), 257–266 (2010).
[Crossref] [PubMed]

Lesiak, M.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Linderman, H. G.

M. W. Zhao Wang, G. C. Jenkins, H. G. Linderman, Y. Bezerra, M. A. Fujino, D. L. Costa, Wilson, and A. M. Rollins, “3-D Stent Detection in Intravascular OCT Using a Bayesian Network and Graph Search,” IEEE Trans. Med. Imaging 34(7), 1549–1561 (2015).
[Crossref] [PubMed]

Lortkipanidze, N.

G. Guagliumi, V. Sirbu, G. Musumeci, R. Gerber, G. Biondi-Zoccai, H. Ikejima, E. Ladich, N. Lortkipanidze, A. Matiashvili, O. Valsecchi, R. Virmani, and G. W. Stone, “Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging,” JACC Cardiovasc. Interv. 5(1), 12–20 (2012).
[Crossref] [PubMed]

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

Lu, H.

Lüscher, T. F.

T. F. Lüscher, J. Steffel, F. R. Eberli, M. Joner, G. Nakazawa, F. C. Tanner, and R. Virmani, “Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications,” Circulation 115(8), 1051–1058 (2007).
[Crossref] [PubMed]

Maehara, A.

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

Matiashvili, A.

G. Guagliumi, V. Sirbu, G. Musumeci, R. Gerber, G. Biondi-Zoccai, H. Ikejima, E. Ladich, N. Lortkipanidze, A. Matiashvili, O. Valsecchi, R. Virmani, and G. W. Stone, “Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging,” JACC Cardiovasc. Interv. 5(1), 12–20 (2012).
[Crossref] [PubMed]

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

Mattesini, A.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

McClean, D.

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

McFadden, E. P.

A. T. L. Ong, E. P. McFadden, E. Regar, P. P. T. de Jaegere, R. T. van Domburg, and P. W. Serruys, “Late angiographic stent thrombosis (LAST) events with drug-eluting stents,” J. Am. Coll. Cardiol. 45(12), 2088–2092 (2005).
[Crossref] [PubMed]

McMahon, S.

S. McMahon, N. Bertollo, E. D. O. Cearbhaill, J. Salber, L. Pierucci, P. Duffy, T. Dürig, V. Bi, and W. Wang, “Bio-resorbable polymer stents: a review of material progress and prospects,” Prog. Polym. Sci. 83, 79–96 (2018).
[Crossref]

Mehanna, E.

D. Prabhu, E. Mehanna, M. Gargesha, D. Wen, E. Brandt, N. S. van Ditzhuijzen, D. Chamie, H. Yamamoto, Y. Fujino, A. Farmazilian, J. Patel, M. Costa, H. G. Bezerra, and D. L. Wilson, “3D registration of intravascular optical coherence tomography and cryo-image volumes for microscopic-resolution validation,” Proc SPIE Int Soc Opt Eng9788, (2016).

Mehilli, J.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Mehran, R.

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

Mihalcsik, L.

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

Milewski, K.

J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, F. D. Kolodgie, G. L. Kaluza, M. B. Leon, and R. Virmani, “Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix,” Circ. Cardiovasc. Interv. 3(3), 257–266 (2010).
[Crossref] [PubMed]

Mintz, G. S.

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

Mont, E. K.

M. Joner, A. V. Finn, A. Farb, E. K. Mont, F. D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H. K. Gold, and R. Virmani, “Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk,” J. Am. Coll. Cardiol. 48(1), 193–202 (2006).
[Crossref] [PubMed]

Mueller, C.

M. Pfisterer, H. P. Brunner-La Rocca, P. T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, C. Kaiser, and BASKET-LATE Investigators, “Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents,” J. Am. Coll. Cardiol. 48(12), 2584–2591 (2006).
[Crossref] [PubMed]

Münzel, T.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Musumeci, G.

G. Guagliumi, V. Sirbu, G. Musumeci, R. Gerber, G. Biondi-Zoccai, H. Ikejima, E. Ladich, N. Lortkipanidze, A. Matiashvili, O. Valsecchi, R. Virmani, and G. W. Stone, “Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging,” JACC Cardiovasc. Interv. 5(1), 12–20 (2012).
[Crossref] [PubMed]

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

Naber, C.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Naganuma, T.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Nakatani, S.

Nakazawa, G.

J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, F. D. Kolodgie, G. L. Kaluza, M. B. Leon, and R. Virmani, “Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix,” Circ. Cardiovasc. Interv. 3(3), 257–266 (2010).
[Crossref] [PubMed]

T. F. Lüscher, J. Steffel, F. R. Eberli, M. Joner, G. Nakazawa, F. C. Tanner, and R. Virmani, “Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications,” Circulation 115(8), 1051–1058 (2007).
[Crossref] [PubMed]

A. V. Finn, M. Joner, G. Nakazawa, F. Kolodgie, J. Newell, M. C. John, H. K. Gold, and R. Virmani, “Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization,” Circulation 115(18), 2435–2441 (2007).
[Crossref] [PubMed]

Nam, H. S.

H. S. Nam, C.-S. Kim, J. J. Lee, J. W. Song, J. W. Kim, and H. Yoo, “Automated detection of vessel lumen and stent struts in intravascular optical coherence tomography to evaluate stent apposition and neointimal coverage,” Med. Phys. 43(4), 1662–1675 (2016).
[Crossref] [PubMed]

Namiki, A.

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

Nef, H.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Newell, J.

A. V. Finn, M. Joner, G. Nakazawa, F. Kolodgie, J. Newell, M. C. John, H. K. Gold, and R. Virmani, “Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization,” Circulation 115(18), 2435–2441 (2007).
[Crossref] [PubMed]

Nikiforidis, G. C.

S. Tsantis, G. C. Kagadis, K. Katsanos, D. Karnabatidis, G. Bourantas, and G. C. Nikiforidis, “Automatic vessel lumen segmentation and stent strut detection in intravascular optical coherence tomography,” Med. Phys. 39(1), 503–513 (2011).
[Crossref] [PubMed]

Ong, A. T. L.

A. T. L. Ong, E. P. McFadden, E. Regar, P. P. T. de Jaegere, R. T. van Domburg, and P. W. Serruys, “Late angiographic stent thrombosis (LAST) events with drug-eluting stents,” J. Am. Coll. Cardiol. 45(12), 2088–2092 (2005).
[Crossref] [PubMed]

Onsea, K.

T. Adriaenssens, G. J. Ughi, C. Dubois, K. Onsea, D. De Cock, J. Bennett, S. Wiyono, M. Vanhaverbeke, P. Sinnaeve, A. Belmans, J. D’hooge, and W. Desmet, “Automated detection and quantification of clusters of malapposed and uncovered intracoronary stent struts assessed with optical coherence tomography,” Int. J. Cardiovasc. Imaging 30(5), 839–848 (2014).
[Crossref] [PubMed]

Onuma, Y.

J. M. Fam, C. Felix, R. J. van Geuns, Y. Onuma, N. M. Van Mieghem, A. Karanasos, J. van der Sijde, M. De Paolis, E. Regar, M. Valgimigli, J. Daemen, P. de Jaegere, F. Zijlstra, and R. Diletti, “Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study,” EuroIntervention 12(1), 30–37 (2016).
[Crossref] [PubMed]

C. M. Felix, J. M. Fam, R. Diletti, Y. Ishibashi, A. Karanasos, B. R. C. Everaert, N. M. D. A. van Mieghem, J. Daemen, P. P. T. de Jaegere, F. Zijlstra, E. S. Regar, Y. Onuma, and R.-J. M. van Geuns, “Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry,” JACC Cardiovasc. Interv. 9(16), 1652–1663 (2016).
[Crossref] [PubMed]

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

B. Chevalier, Y. Onuma, A. J. van Boven, J. J. Piek, M. Sabaté, S. Helqvist, A. Baumbach, P. C. Smits, R. Kumar, L. Wasungu, and P. W. Serruys, “Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial,” EuroIntervention 12(9), 1102–1107 (2016).
[Crossref] [PubMed]

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

Y. Ishibashi, S. Nakatani, and Y. Onuma, “Definite and probable bioresorbable scaffold thrombosis in stable and ACS patients,” EuroIntervention 11(3), e1–e2 (2015).
[Crossref] [PubMed]

A. Wang, S. Nakatani, J. Eggermont, Y. Onuma, H. M. Garcia-Garcia, P. W. Serruys, J. H. C. Reiber, and J. Dijkstra, “Automatic detection of bioresorbable vascular scaffold struts in intravascular optical coherence tomography pullback runs,” Biomed. Opt. Express 5(10), 3589–3602 (2014).
[Crossref] [PubMed]

P. W. Serruys, H. M. Garcia-Garcia, and Y. Onuma, “From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?” Eur. Heart J. 33(1), 16–25 (2012).
[Crossref] [PubMed]

Osswald, S.

M. Pfisterer, H. P. Brunner-La Rocca, P. T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, C. Kaiser, and BASKET-LATE Investigators, “Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents,” J. Am. Coll. Cardiol. 48(12), 2584–2591 (2006).
[Crossref] [PubMed]

Ozaki, Y.

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

Parise, H.

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

Park, S.-J.

I.-K. Jang, B. E. Bouma, D.-H. Kang, S.-J. Park, S.-W. Park, K.-B. Seung, K.-B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S. L. Houser, H. T. Aretz, and G. J. Tearney, “Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound,” J. Am. Coll. Cardiol. 39(4), 604–609 (2002).
[Crossref] [PubMed]

Park, S.-W.

I.-K. Jang, B. E. Bouma, D.-H. Kang, S.-J. Park, S.-W. Park, K.-B. Seung, K.-B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S. L. Houser, H. T. Aretz, and G. J. Tearney, “Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound,” J. Am. Coll. Cardiol. 39(4), 604–609 (2002).
[Crossref] [PubMed]

Parker, S.

J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, F. D. Kolodgie, G. L. Kaluza, M. B. Leon, and R. Virmani, “Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix,” Circ. Cardiovasc. Interv. 3(3), 257–266 (2010).
[Crossref] [PubMed]

Patel, J.

D. Prabhu, E. Mehanna, M. Gargesha, D. Wen, E. Brandt, N. S. van Ditzhuijzen, D. Chamie, H. Yamamoto, Y. Fujino, A. Farmazilian, J. Patel, M. Costa, H. G. Bezerra, and D. L. Wilson, “3D registration of intravascular optical coherence tomography and cryo-image volumes for microscopic-resolution validation,” Proc SPIE Int Soc Opt Eng9788, (2016).

Pawar, R.

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

Pfisterer, M.

M. Pfisterer, H. P. Brunner-La Rocca, P. T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, C. Kaiser, and BASKET-LATE Investigators, “Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents,” J. Am. Coll. Cardiol. 48(12), 2584–2591 (2006).
[Crossref] [PubMed]

Pfisterer, M. E.

M. E. Pfisterer, “Late Stent Thrombosis After Drug-Eluting Stent Implantation for Acute Myocardial Infarction: A New Red Flag is Raised,” Circulation 118(11), 1117–1119 (2008).
[Crossref] [PubMed]

Piek, J. J.

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

B. Chevalier, Y. Onuma, A. J. van Boven, J. J. Piek, M. Sabaté, S. Helqvist, A. Baumbach, P. C. Smits, R. Kumar, L. Wasungu, and P. W. Serruys, “Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial,” EuroIntervention 12(9), 1102–1107 (2016).
[Crossref] [PubMed]

M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, and R. J. de Winter, “Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study,” Eur. Heart J. 31(9), 1055–1064 (2010).
[Crossref] [PubMed]

Pierucci, L.

S. McMahon, N. Bertollo, E. D. O. Cearbhaill, J. Salber, L. Pierucci, P. Duffy, T. Dürig, V. Bi, and W. Wang, “Bio-resorbable polymer stents: a review of material progress and prospects,” Prog. Polym. Sci. 83, 79–96 (2018).
[Crossref]

Pomerantsev, E.

I.-K. Jang, B. E. Bouma, D.-H. Kang, S.-J. Park, S.-W. Park, K.-B. Seung, K.-B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S. L. Houser, H. T. Aretz, and G. J. Tearney, “Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound,” J. Am. Coll. Cardiol. 39(4), 604–609 (2002).
[Crossref] [PubMed]

Popma, J. J.

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

Prabhu, D.

C. Kolluru, D. Prabhu, Y. Gharaibeh, H. Bezerra, G. Guagliumi, and D. Wilson, “Deep neural networks for A-line-based plaque classification in coronary intravascular optical coherence tomography images,” J. Med. Imaging (Bellingham) 5(4), 044504 (2018).
[Crossref] [PubMed]

C. Kolluru, D. Prabhu, Y. Gharaibeh, H. Wu, and D. L. Wilson, “Voxel-based plaque classification in coronary intravascular optical coherence tomography images using decision trees,” Proc SPIE Int Soc Opt Eng10575, (2018).
[Crossref]

R. Shalev, H. G. Bezerra, S. Ray, D. Prabhu, and D. L. Wilson, “Classification of calcium in intravascular OCT images for the purpose of intervention planning,” Proc SPIE Int Soc Opt Eng9786, (2016).

D. Prabhu, E. Mehanna, M. Gargesha, D. Wen, E. Brandt, N. S. van Ditzhuijzen, D. Chamie, H. Yamamoto, Y. Fujino, A. Farmazilian, J. Patel, M. Costa, H. G. Bezerra, and D. L. Wilson, “3D registration of intravascular optical coherence tomography and cryo-image volumes for microscopic-resolution validation,” Proc SPIE Int Soc Opt Eng9788, (2016).

Pyxaras, S.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Rapoza, R.

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

Ray, S.

H. Lu, M. Gargesha, Z. Wang, D. Chamie, G. F. Attizzani, T. Kanaya, S. Ray, M. A. Costa, A. M. Rollins, H. G. Bezerra, and D. L. Wilson, “Automatic stent detection in intravascular OCT images using bagged decision trees,” Biomed. Opt. Express 3(11), 2809–2824 (2012).
[Crossref] [PubMed]

R. Shalev, H. G. Bezerra, S. Ray, D. Prabhu, and D. L. Wilson, “Classification of calcium in intravascular OCT images for the purpose of intervention planning,” Proc SPIE Int Soc Opt Eng9786, (2016).

Regar, E.

J. M. Fam, C. Felix, R. J. van Geuns, Y. Onuma, N. M. Van Mieghem, A. Karanasos, J. van der Sijde, M. De Paolis, E. Regar, M. Valgimigli, J. Daemen, P. de Jaegere, F. Zijlstra, and R. Diletti, “Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study,” EuroIntervention 12(1), 30–37 (2016).
[Crossref] [PubMed]

A. T. L. Ong, E. P. McFadden, E. Regar, P. P. T. de Jaegere, R. T. van Domburg, and P. W. Serruys, “Late angiographic stent thrombosis (LAST) events with drug-eluting stents,” J. Am. Coll. Cardiol. 45(12), 2088–2092 (2005).
[Crossref] [PubMed]

Regar, E. S.

C. M. Felix, J. M. Fam, R. Diletti, Y. Ishibashi, A. Karanasos, B. R. C. Everaert, N. M. D. A. van Mieghem, J. Daemen, P. P. T. de Jaegere, F. Zijlstra, E. S. Regar, Y. Onuma, and R.-J. M. van Geuns, “Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry,” JACC Cardiovasc. Interv. 9(16), 1652–1663 (2016).
[Crossref] [PubMed]

Reiber, J. H. C.

A. Wang, S. Nakatani, J. Eggermont, Y. Onuma, H. M. Garcia-Garcia, P. W. Serruys, J. H. C. Reiber, and J. Dijkstra, “Automatic detection of bioresorbable vascular scaffold struts in intravascular optical coherence tomography pullback runs,” Biomed. Opt. Express 5(10), 3589–3602 (2014).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

Reith, S.

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

Rickenbacher, P.

M. Pfisterer, H. P. Brunner-La Rocca, P. T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, C. Kaiser, and BASKET-LATE Investigators, “Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents,” J. Am. Coll. Cardiol. 48(12), 2584–2591 (2006).
[Crossref] [PubMed]

Rikhtegar, F.

J. M. Amrute, L. S. Athanasiou, F. Rikhtegar, J. M. de la Torre Hernández, T. G. Camarero, and E. R. Edelman, “Polymeric endovascular strut and lumen detection algorithm for intracoronary optical coherence tomography images,” J. Biomed. Opt. 23(3), 1–14 (2018).
[Crossref] [PubMed]

Rollins, A. M.

M. W. Zhao Wang, G. C. Jenkins, H. G. Linderman, Y. Bezerra, M. A. Fujino, D. L. Costa, Wilson, and A. M. Rollins, “3-D Stent Detection in Intravascular OCT Using a Bayesian Network and Graph Search,” IEEE Trans. Med. Imaging 34(7), 1549–1561 (2015).
[Crossref] [PubMed]

H. Lu, M. Gargesha, Z. Wang, D. Chamie, G. F. Attizzani, T. Kanaya, S. Ray, M. A. Costa, A. M. Rollins, H. G. Bezerra, and D. L. Wilson, “Automatic stent detection in intravascular OCT images using bagged decision trees,” Biomed. Opt. Express 3(11), 2809–2824 (2012).
[Crossref] [PubMed]

Z. Wang, D. Chamie, H. G. Bezerra, H. Yamamoto, J. Kanovsky, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Volumetric quantification of fibrous caps using intravascular optical coherence tomography,” Biomed. Opt. Express 3(6), 1413–1426 (2012).
[Crossref] [PubMed]

Z. Wang, H. Kyono, H. G. Bezerra, H. Wang, M. Gargesha, C. Alraies, C. Xu, J. M. Schmitt, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Semiautomatic segmentation and quantification of calcified plaques in intracoronary optical coherence tomography images,” J. Biomed. Opt. 15(6), 061711 (2010).
[Crossref] [PubMed]

H. G. Bezerra, M. A. Costa, G. Guagliumi, A. M. Rollins, and D. I. Simon, “Intracoronary optical coherence tomography: a comprehensive review clinical and research applications,” JACC Cardiovasc. Interv. 2(11), 1035–1046 (2009).
[Crossref] [PubMed]

Rowland, S.

J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, F. D. Kolodgie, G. L. Kaluza, M. B. Leon, and R. Virmani, “Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix,” Circ. Cardiovasc. Interv. 3(3), 257–266 (2010).
[Crossref] [PubMed]

Sabaté, M.

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

B. Chevalier, Y. Onuma, A. J. van Boven, J. J. Piek, M. Sabaté, S. Helqvist, A. Baumbach, P. C. Smits, R. Kumar, L. Wasungu, and P. W. Serruys, “Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial,” EuroIntervention 12(9), 1102–1107 (2016).
[Crossref] [PubMed]

Salber, J.

S. McMahon, N. Bertollo, E. D. O. Cearbhaill, J. Salber, L. Pierucci, P. Duffy, T. Dürig, V. Bi, and W. Wang, “Bio-resorbable polymer stents: a review of material progress and prospects,” Prog. Polym. Sci. 83, 79–96 (2018).
[Crossref]

Scheunhage, E.

M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, and R. J. de Winter, “Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study,” Eur. Heart J. 31(9), 1055–1064 (2010).
[Crossref] [PubMed]

Schlendorf, K.

I.-K. Jang, B. E. Bouma, D.-H. Kang, S.-J. Park, S.-W. Park, K.-B. Seung, K.-B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S. L. Houser, H. T. Aretz, and G. J. Tearney, “Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound,” J. Am. Coll. Cardiol. 39(4), 604–609 (2002).
[Crossref] [PubMed]

Schmitt, J. M.

C. Xu, J. M. Schmitt, T. Akasaka, T. Kubo, and K. Huang, “Automatic detection of stent struts with thick neointimal growth in intravascular optical coherence tomography image sequences,” Phys. Med. Biol. 56(20), 6665–6675 (2011).
[Crossref] [PubMed]

Z. Wang, H. Kyono, H. G. Bezerra, H. Wang, M. Gargesha, C. Alraies, C. Xu, J. M. Schmitt, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Semiautomatic segmentation and quantification of calcified plaques in intracoronary optical coherence tomography images,” J. Biomed. Opt. 15(6), 061711 (2010).
[Crossref] [PubMed]

Serruys, P. W.

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

B. Chevalier, Y. Onuma, A. J. van Boven, J. J. Piek, M. Sabaté, S. Helqvist, A. Baumbach, P. C. Smits, R. Kumar, L. Wasungu, and P. W. Serruys, “Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial,” EuroIntervention 12(9), 1102–1107 (2016).
[Crossref] [PubMed]

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

A. Wang, S. Nakatani, J. Eggermont, Y. Onuma, H. M. Garcia-Garcia, P. W. Serruys, J. H. C. Reiber, and J. Dijkstra, “Automatic detection of bioresorbable vascular scaffold struts in intravascular optical coherence tomography pullback runs,” Biomed. Opt. Express 5(10), 3589–3602 (2014).
[Crossref] [PubMed]

P. W. Serruys, H. M. Garcia-Garcia, and Y. Onuma, “From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?” Eur. Heart J. 33(1), 16–25 (2012).
[Crossref] [PubMed]

A. T. L. Ong, E. P. McFadden, E. Regar, P. P. T. de Jaegere, R. T. van Domburg, and P. W. Serruys, “Late angiographic stent thrombosis (LAST) events with drug-eluting stents,” J. Am. Coll. Cardiol. 45(12), 2088–2092 (2005).
[Crossref] [PubMed]

Seung, K.-B.

I.-K. Jang, B. E. Bouma, D.-H. Kang, S.-J. Park, S.-W. Park, K.-B. Seung, K.-B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S. L. Houser, H. T. Aretz, and G. J. Tearney, “Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound,” J. Am. Coll. Cardiol. 39(4), 604–609 (2002).
[Crossref] [PubMed]

Shalev, R.

R. Shalev, H. G. Bezerra, S. Ray, D. Prabhu, and D. L. Wilson, “Classification of calcium in intravascular OCT images for the purpose of intervention planning,” Proc SPIE Int Soc Opt Eng9786, (2016).

Shiomi, H.

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

Shishkov, M.

I.-K. Jang, B. E. Bouma, D.-H. Kang, S.-J. Park, S.-W. Park, K.-B. Seung, K.-B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S. L. Houser, H. T. Aretz, and G. J. Tearney, “Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound,” J. Am. Coll. Cardiol. 39(4), 604–609 (2002).
[Crossref] [PubMed]

Simon, D. I.

H. G. Bezerra, M. A. Costa, G. Guagliumi, A. M. Rollins, and D. I. Simon, “Intracoronary optical coherence tomography: a comprehensive review clinical and research applications,” JACC Cardiovasc. Interv. 2(11), 1035–1046 (2009).
[Crossref] [PubMed]

Simonton, C.

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

Sinnaeve, P.

T. Adriaenssens, G. J. Ughi, C. Dubois, K. Onsea, D. De Cock, J. Bennett, S. Wiyono, M. Vanhaverbeke, P. Sinnaeve, A. Belmans, J. D’hooge, and W. Desmet, “Automated detection and quantification of clusters of malapposed and uncovered intracoronary stent struts assessed with optical coherence tomography,” Int. J. Cardiovasc. Imaging 30(5), 839–848 (2014).
[Crossref] [PubMed]

G. J. Ughi, C. J. Van Dyck, T. Adriaenssens, V. Y. Hoymans, P. Sinnaeve, J.-P. Timmermans, W. Desmet, C. J. Vrints, and J. D’hooge, “Automatic assessment of stent neointimal coverage by intravascular optical coherence tomography,” Eur. Heart J. Cardiovasc. Imaging 15(2), 195–200 (2014).
[Crossref] [PubMed]

Sirbu, V.

G. Guagliumi, V. Sirbu, G. Musumeci, R. Gerber, G. Biondi-Zoccai, H. Ikejima, E. Ladich, N. Lortkipanidze, A. Matiashvili, O. Valsecchi, R. Virmani, and G. W. Stone, “Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging,” JACC Cardiovasc. Interv. 5(1), 12–20 (2012).
[Crossref] [PubMed]

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

Skorija, K.

M. Joner, A. V. Finn, A. Farb, E. K. Mont, F. D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H. K. Gold, and R. Virmani, “Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk,” J. Am. Coll. Cardiol. 48(1), 193–202 (2006).
[Crossref] [PubMed]

Smits, P. C.

B. Chevalier, Y. Onuma, A. J. van Boven, J. J. Piek, M. Sabaté, S. Helqvist, A. Baumbach, P. C. Smits, R. Kumar, L. Wasungu, and P. W. Serruys, “Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial,” EuroIntervention 12(9), 1102–1107 (2016).
[Crossref] [PubMed]

Song, J. W.

H. S. Nam, C.-S. Kim, J. J. Lee, J. W. Song, J. W. Kim, and H. Yoo, “Automated detection of vessel lumen and stent struts in intravascular optical coherence tomography to evaluate stent apposition and neointimal coverage,” Med. Phys. 43(4), 1662–1675 (2016).
[Crossref] [PubMed]

Sotomi, Y.

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

Steffel, J.

T. F. Lüscher, J. Steffel, F. R. Eberli, M. Joner, G. Nakazawa, F. C. Tanner, and R. Virmani, “Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications,” Circulation 115(8), 1051–1058 (2007).
[Crossref] [PubMed]

Stone, G. W.

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

G. Guagliumi, V. Sirbu, G. Musumeci, R. Gerber, G. Biondi-Zoccai, H. Ikejima, E. Ladich, N. Lortkipanidze, A. Matiashvili, O. Valsecchi, R. Virmani, and G. W. Stone, “Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging,” JACC Cardiovasc. Interv. 5(1), 12–20 (2012).
[Crossref] [PubMed]

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

Suzuki, N.

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

Tamburino, C.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Tanabe, K.

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

Tanner, F. C.

T. F. Lüscher, J. Steffel, F. R. Eberli, M. Joner, G. Nakazawa, F. C. Tanner, and R. Virmani, “Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications,” Circulation 115(8), 1051–1058 (2007).
[Crossref] [PubMed]

Tearney, G. J.

I.-K. Jang, B. E. Bouma, D.-H. Kang, S.-J. Park, S.-W. Park, K.-B. Seung, K.-B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S. L. Houser, H. T. Aretz, and G. J. Tearney, “Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound,” J. Am. Coll. Cardiol. 39(4), 604–609 (2002).
[Crossref] [PubMed]

Tellez, A.

J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, F. D. Kolodgie, G. L. Kaluza, M. B. Leon, and R. Virmani, “Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix,” Circ. Cardiovasc. Interv. 3(3), 257–266 (2010).
[Crossref] [PubMed]

Tijssen, J. G. P.

M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, and R. J. de Winter, “Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study,” Eur. Heart J. 31(9), 1055–1064 (2010).
[Crossref] [PubMed]

Timmermans, J.-P.

G. J. Ughi, C. J. Van Dyck, T. Adriaenssens, V. Y. Hoymans, P. Sinnaeve, J.-P. Timmermans, W. Desmet, C. J. Vrints, and J. D’hooge, “Automatic assessment of stent neointimal coverage by intravascular optical coherence tomography,” Eur. Heart J. Cardiovasc. Imaging 15(2), 195–200 (2014).
[Crossref] [PubMed]

Trivisonno, A.

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

Tsantis, S.

S. Tsantis, G. C. Kagadis, K. Katsanos, D. Karnabatidis, G. Bourantas, and G. C. Nikiforidis, “Automatic vessel lumen segmentation and stent strut detection in intravascular optical coherence tomography,” Med. Phys. 39(1), 503–513 (2011).
[Crossref] [PubMed]

Ueno, T.

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

Ughi, G. J.

T. Adriaenssens, G. J. Ughi, C. Dubois, K. Onsea, D. De Cock, J. Bennett, S. Wiyono, M. Vanhaverbeke, P. Sinnaeve, A. Belmans, J. D’hooge, and W. Desmet, “Automated detection and quantification of clusters of malapposed and uncovered intracoronary stent struts assessed with optical coherence tomography,” Int. J. Cardiovasc. Imaging 30(5), 839–848 (2014).
[Crossref] [PubMed]

G. J. Ughi, C. J. Van Dyck, T. Adriaenssens, V. Y. Hoymans, P. Sinnaeve, J.-P. Timmermans, W. Desmet, C. J. Vrints, and J. D’hooge, “Automatic assessment of stent neointimal coverage by intravascular optical coherence tomography,” Eur. Heart J. Cardiovasc. Imaging 15(2), 195–200 (2014).
[Crossref] [PubMed]

Valgimigli, M.

J. M. Fam, C. Felix, R. J. van Geuns, Y. Onuma, N. M. Van Mieghem, A. Karanasos, J. van der Sijde, M. De Paolis, E. Regar, M. Valgimigli, J. Daemen, P. de Jaegere, F. Zijlstra, and R. Diletti, “Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study,” EuroIntervention 12(1), 30–37 (2016).
[Crossref] [PubMed]

Valsecchi, O.

G. Guagliumi, V. Sirbu, G. Musumeci, R. Gerber, G. Biondi-Zoccai, H. Ikejima, E. Ladich, N. Lortkipanidze, A. Matiashvili, O. Valsecchi, R. Virmani, and G. W. Stone, “Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging,” JACC Cardiovasc. Interv. 5(1), 12–20 (2012).
[Crossref] [PubMed]

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

van Boven, A. J.

B. Chevalier, Y. Onuma, A. J. van Boven, J. J. Piek, M. Sabaté, S. Helqvist, A. Baumbach, P. C. Smits, R. Kumar, L. Wasungu, and P. W. Serruys, “Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial,” EuroIntervention 12(9), 1102–1107 (2016).
[Crossref] [PubMed]

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

van der Sijde, J.

J. M. Fam, C. Felix, R. J. van Geuns, Y. Onuma, N. M. Van Mieghem, A. Karanasos, J. van der Sijde, M. De Paolis, E. Regar, M. Valgimigli, J. Daemen, P. de Jaegere, F. Zijlstra, and R. Diletti, “Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study,” EuroIntervention 12(1), 30–37 (2016).
[Crossref] [PubMed]

van Ditzhuijzen, N. S.

D. Prabhu, E. Mehanna, M. Gargesha, D. Wen, E. Brandt, N. S. van Ditzhuijzen, D. Chamie, H. Yamamoto, Y. Fujino, A. Farmazilian, J. Patel, M. Costa, H. G. Bezerra, and D. L. Wilson, “3D registration of intravascular optical coherence tomography and cryo-image volumes for microscopic-resolution validation,” Proc SPIE Int Soc Opt Eng9788, (2016).

van Domburg, R. T.

A. T. L. Ong, E. P. McFadden, E. Regar, P. P. T. de Jaegere, R. T. van Domburg, and P. W. Serruys, “Late angiographic stent thrombosis (LAST) events with drug-eluting stents,” J. Am. Coll. Cardiol. 45(12), 2088–2092 (2005).
[Crossref] [PubMed]

Van Dyck, C. J.

G. J. Ughi, C. J. Van Dyck, T. Adriaenssens, V. Y. Hoymans, P. Sinnaeve, J.-P. Timmermans, W. Desmet, C. J. Vrints, and J. D’hooge, “Automatic assessment of stent neointimal coverage by intravascular optical coherence tomography,” Eur. Heart J. Cardiovasc. Imaging 15(2), 195–200 (2014).
[Crossref] [PubMed]

van Geloven, N.

M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, and R. J. de Winter, “Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study,” Eur. Heart J. 31(9), 1055–1064 (2010).
[Crossref] [PubMed]

van Geuns, R. J.

J. M. Fam, C. Felix, R. J. van Geuns, Y. Onuma, N. M. Van Mieghem, A. Karanasos, J. van der Sijde, M. De Paolis, E. Regar, M. Valgimigli, J. Daemen, P. de Jaegere, F. Zijlstra, and R. Diletti, “Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study,” EuroIntervention 12(1), 30–37 (2016).
[Crossref] [PubMed]

van Geuns, R.-J. M.

C. M. Felix, J. M. Fam, R. Diletti, Y. Ishibashi, A. Karanasos, B. R. C. Everaert, N. M. D. A. van Mieghem, J. Daemen, P. P. T. de Jaegere, F. Zijlstra, E. S. Regar, Y. Onuma, and R.-J. M. van Geuns, “Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry,” JACC Cardiovasc. Interv. 9(16), 1652–1663 (2016).
[Crossref] [PubMed]

Van Mieghem, N. M.

J. M. Fam, C. Felix, R. J. van Geuns, Y. Onuma, N. M. Van Mieghem, A. Karanasos, J. van der Sijde, M. De Paolis, E. Regar, M. Valgimigli, J. Daemen, P. de Jaegere, F. Zijlstra, and R. Diletti, “Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study,” EuroIntervention 12(1), 30–37 (2016).
[Crossref] [PubMed]

van Mieghem, N. M. D. A.

C. M. Felix, J. M. Fam, R. Diletti, Y. Ishibashi, A. Karanasos, B. R. C. Everaert, N. M. D. A. van Mieghem, J. Daemen, P. P. T. de Jaegere, F. Zijlstra, E. S. Regar, Y. Onuma, and R.-J. M. van Geuns, “Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry,” JACC Cardiovasc. Interv. 9(16), 1652–1663 (2016).
[Crossref] [PubMed]

Vanhaverbeke, M.

T. Adriaenssens, G. J. Ughi, C. Dubois, K. Onsea, D. De Cock, J. Bennett, S. Wiyono, M. Vanhaverbeke, P. Sinnaeve, A. Belmans, J. D’hooge, and W. Desmet, “Automated detection and quantification of clusters of malapposed and uncovered intracoronary stent struts assessed with optical coherence tomography,” Int. J. Cardiovasc. Imaging 30(5), 839–848 (2014).
[Crossref] [PubMed]

Vapnik, V. N.

V. N. Vapnik, “An overview of statistical learning theory,” IEEE Trans. Neural Netw. 10(5), 988–999 (1999).
[Crossref] [PubMed]

Verouden, N. J. W.

M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, and R. J. de Winter, “Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study,” Eur. Heart J. 31(9), 1055–1064 (2010).
[Crossref] [PubMed]

Virmani, R.

G. Guagliumi, V. Sirbu, G. Musumeci, R. Gerber, G. Biondi-Zoccai, H. Ikejima, E. Ladich, N. Lortkipanidze, A. Matiashvili, O. Valsecchi, R. Virmani, and G. W. Stone, “Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging,” JACC Cardiovasc. Interv. 5(1), 12–20 (2012).
[Crossref] [PubMed]

J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, F. D. Kolodgie, G. L. Kaluza, M. B. Leon, and R. Virmani, “Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix,” Circ. Cardiovasc. Interv. 3(3), 257–266 (2010).
[Crossref] [PubMed]

T. F. Lüscher, J. Steffel, F. R. Eberli, M. Joner, G. Nakazawa, F. C. Tanner, and R. Virmani, “Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications,” Circulation 115(8), 1051–1058 (2007).
[Crossref] [PubMed]

A. V. Finn, M. Joner, G. Nakazawa, F. Kolodgie, J. Newell, M. C. John, H. K. Gold, and R. Virmani, “Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization,” Circulation 115(18), 2435–2441 (2007).
[Crossref] [PubMed]

M. Joner, A. V. Finn, A. Farb, E. K. Mont, F. D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H. K. Gold, and R. Virmani, “Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk,” J. Am. Coll. Cardiol. 48(1), 193–202 (2006).
[Crossref] [PubMed]

Vis, M. M.

M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, and R. J. de Winter, “Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study,” Eur. Heart J. 31(9), 1055–1064 (2010).
[Crossref] [PubMed]

Vorpahl, M.

J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, F. D. Kolodgie, G. L. Kaluza, M. B. Leon, and R. Virmani, “Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix,” Circ. Cardiovasc. Interv. 3(3), 257–266 (2010).
[Crossref] [PubMed]

Vrints, C. J.

G. J. Ughi, C. J. Van Dyck, T. Adriaenssens, V. Y. Hoymans, P. Sinnaeve, J.-P. Timmermans, W. Desmet, C. J. Vrints, and J. D’hooge, “Automatic assessment of stent neointimal coverage by intravascular optical coherence tomography,” Eur. Heart J. Cardiovasc. Imaging 15(2), 195–200 (2014).
[Crossref] [PubMed]

Waksman, R.

R. Waksman, “Biodegradable stents: they do their job and disappear,” J. Invasive Cardiol. 18(2), 70–74 (2006).
[PubMed]

Wallace-Bradley, D.

J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, F. D. Kolodgie, G. L. Kaluza, M. B. Leon, and R. Virmani, “Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix,” Circ. Cardiovasc. Interv. 3(3), 257–266 (2010).
[Crossref] [PubMed]

Wang, A.

A. Wang, S. Nakatani, J. Eggermont, Y. Onuma, H. M. Garcia-Garcia, P. W. Serruys, J. H. C. Reiber, and J. Dijkstra, “Automatic detection of bioresorbable vascular scaffold struts in intravascular optical coherence tomography pullback runs,” Biomed. Opt. Express 5(10), 3589–3602 (2014).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

Wang, H.

Z. Wang, H. Kyono, H. G. Bezerra, H. Wang, M. Gargesha, C. Alraies, C. Xu, J. M. Schmitt, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Semiautomatic segmentation and quantification of calcified plaques in intracoronary optical coherence tomography images,” J. Biomed. Opt. 15(6), 061711 (2010).
[Crossref] [PubMed]

Wang, W.

S. McMahon, N. Bertollo, E. D. O. Cearbhaill, J. Salber, L. Pierucci, P. Duffy, T. Dürig, V. Bi, and W. Wang, “Bio-resorbable polymer stents: a review of material progress and prospects,” Prog. Polym. Sci. 83, 79–96 (2018).
[Crossref]

Wang, Z.

Wasungu, L.

B. Chevalier, Y. Onuma, A. J. van Boven, J. J. Piek, M. Sabaté, S. Helqvist, A. Baumbach, P. C. Smits, R. Kumar, L. Wasungu, and P. W. Serruys, “Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial,” EuroIntervention 12(9), 1102–1107 (2016).
[Crossref] [PubMed]

Wen, D.

D. Prabhu, E. Mehanna, M. Gargesha, D. Wen, E. Brandt, N. S. van Ditzhuijzen, D. Chamie, H. Yamamoto, Y. Fujino, A. Farmazilian, J. Patel, M. Costa, H. G. Bezerra, and D. L. Wilson, “3D registration of intravascular optical coherence tomography and cryo-image volumes for microscopic-resolution validation,” Proc SPIE Int Soc Opt Eng9788, (2016).

Wiebe, J.

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Wilson,

M. W. Zhao Wang, G. C. Jenkins, H. G. Linderman, Y. Bezerra, M. A. Fujino, D. L. Costa, Wilson, and A. M. Rollins, “3-D Stent Detection in Intravascular OCT Using a Bayesian Network and Graph Search,” IEEE Trans. Med. Imaging 34(7), 1549–1561 (2015).
[Crossref] [PubMed]

Wilson, D.

C. Kolluru, D. Prabhu, Y. Gharaibeh, H. Bezerra, G. Guagliumi, and D. Wilson, “Deep neural networks for A-line-based plaque classification in coronary intravascular optical coherence tomography images,” J. Med. Imaging (Bellingham) 5(4), 044504 (2018).
[Crossref] [PubMed]

Wilson, D. L.

Z. Wang, D. Chamie, H. G. Bezerra, H. Yamamoto, J. Kanovsky, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Volumetric quantification of fibrous caps using intravascular optical coherence tomography,” Biomed. Opt. Express 3(6), 1413–1426 (2012).
[Crossref] [PubMed]

H. Lu, M. Gargesha, Z. Wang, D. Chamie, G. F. Attizzani, T. Kanaya, S. Ray, M. A. Costa, A. M. Rollins, H. G. Bezerra, and D. L. Wilson, “Automatic stent detection in intravascular OCT images using bagged decision trees,” Biomed. Opt. Express 3(11), 2809–2824 (2012).
[Crossref] [PubMed]

Z. Wang, H. Kyono, H. G. Bezerra, H. Wang, M. Gargesha, C. Alraies, C. Xu, J. M. Schmitt, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Semiautomatic segmentation and quantification of calcified plaques in intracoronary optical coherence tomography images,” J. Biomed. Opt. 15(6), 061711 (2010).
[Crossref] [PubMed]

R. Shalev, H. G. Bezerra, S. Ray, D. Prabhu, and D. L. Wilson, “Classification of calcium in intravascular OCT images for the purpose of intervention planning,” Proc SPIE Int Soc Opt Eng9786, (2016).

C. Kolluru, D. Prabhu, Y. Gharaibeh, H. Wu, and D. L. Wilson, “Voxel-based plaque classification in coronary intravascular optical coherence tomography images using decision trees,” Proc SPIE Int Soc Opt Eng10575, (2018).
[Crossref]

D. Prabhu, E. Mehanna, M. Gargesha, D. Wen, E. Brandt, N. S. van Ditzhuijzen, D. Chamie, H. Yamamoto, Y. Fujino, A. Farmazilian, J. Patel, M. Costa, H. G. Bezerra, and D. L. Wilson, “3D registration of intravascular optical coherence tomography and cryo-image volumes for microscopic-resolution validation,” Proc SPIE Int Soc Opt Eng9788, (2016).

Windecker, S.

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

Wiyono, S.

T. Adriaenssens, G. J. Ughi, C. Dubois, K. Onsea, D. De Cock, J. Bennett, S. Wiyono, M. Vanhaverbeke, P. Sinnaeve, A. Belmans, J. D’hooge, and W. Desmet, “Automated detection and quantification of clusters of malapposed and uncovered intracoronary stent struts assessed with optical coherence tomography,” Int. J. Cardiovasc. Imaging 30(5), 839–848 (2014).
[Crossref] [PubMed]

Wu, H.

C. Kolluru, D. Prabhu, Y. Gharaibeh, H. Wu, and D. L. Wilson, “Voxel-based plaque classification in coronary intravascular optical coherence tomography images using decision trees,” Proc SPIE Int Soc Opt Eng10575, (2018).
[Crossref]

Xu, C.

C. Xu, J. M. Schmitt, T. Akasaka, T. Kubo, and K. Huang, “Automatic detection of stent struts with thick neointimal growth in intravascular optical coherence tomography image sequences,” Phys. Med. Biol. 56(20), 6665–6675 (2011).
[Crossref] [PubMed]

Z. Wang, H. Kyono, H. G. Bezerra, H. Wang, M. Gargesha, C. Alraies, C. Xu, J. M. Schmitt, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Semiautomatic segmentation and quantification of calcified plaques in intracoronary optical coherence tomography images,” J. Biomed. Opt. 15(6), 061711 (2010).
[Crossref] [PubMed]

Yamamoto, H.

Z. Wang, D. Chamie, H. G. Bezerra, H. Yamamoto, J. Kanovsky, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Volumetric quantification of fibrous caps using intravascular optical coherence tomography,” Biomed. Opt. Express 3(6), 1413–1426 (2012).
[Crossref] [PubMed]

D. Prabhu, E. Mehanna, M. Gargesha, D. Wen, E. Brandt, N. S. van Ditzhuijzen, D. Chamie, H. Yamamoto, Y. Fujino, A. Farmazilian, J. Patel, M. Costa, H. G. Bezerra, and D. L. Wilson, “3D registration of intravascular optical coherence tomography and cryo-image volumes for microscopic-resolution validation,” Proc SPIE Int Soc Opt Eng9788, (2016).

Yasuda, S.

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

Yoo, H.

H. S. Nam, C.-S. Kim, J. J. Lee, J. W. Song, J. W. Kim, and H. Yoo, “Automated detection of vessel lumen and stent struts in intravascular optical coherence tomography to evaluate stent apposition and neointimal coverage,” Med. Phys. 43(4), 1662–1675 (2016).
[Crossref] [PubMed]

Zhao Wang, M. W.

M. W. Zhao Wang, G. C. Jenkins, H. G. Linderman, Y. Bezerra, M. A. Fujino, D. L. Costa, Wilson, and A. M. Rollins, “3-D Stent Detection in Intravascular OCT Using a Bayesian Network and Graph Search,” IEEE Trans. Med. Imaging 34(7), 1549–1561 (2015).
[Crossref] [PubMed]

Zijlstra, F.

J. M. Fam, C. Felix, R. J. van Geuns, Y. Onuma, N. M. Van Mieghem, A. Karanasos, J. van der Sijde, M. De Paolis, E. Regar, M. Valgimigli, J. Daemen, P. de Jaegere, F. Zijlstra, and R. Diletti, “Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study,” EuroIntervention 12(1), 30–37 (2016).
[Crossref] [PubMed]

C. M. Felix, J. M. Fam, R. Diletti, Y. Ishibashi, A. Karanasos, B. R. C. Everaert, N. M. D. A. van Mieghem, J. Daemen, P. P. T. de Jaegere, F. Zijlstra, E. S. Regar, Y. Onuma, and R.-J. M. van Geuns, “Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry,” JACC Cardiovasc. Interv. 9(16), 1652–1663 (2016).
[Crossref] [PubMed]

Am. Heart J. (1)

M. S. Chen, J. M. John, D. P. Chew, D. S. Lee, S. G. Ellis, and D. L. Bhatt, “Bare metal stent restenosis is not a benign clinical entity,” Am. Heart J. 151(6), 1260–1264 (2006).
[Crossref] [PubMed]

Biomed. Opt. Express (3)

Circ. Cardiovasc. Interv. (1)

J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, F. D. Kolodgie, G. L. Kaluza, M. B. Leon, and R. Virmani, “Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix,” Circ. Cardiovasc. Interv. 3(3), 257–266 (2010).
[Crossref] [PubMed]

Circulation (4)

M. E. Pfisterer, “Late Stent Thrombosis After Drug-Eluting Stent Implantation for Acute Myocardial Infarction: A New Red Flag is Raised,” Circulation 118(11), 1117–1119 (2008).
[Crossref] [PubMed]

T. F. Lüscher, J. Steffel, F. R. Eberli, M. Joner, G. Nakazawa, F. C. Tanner, and R. Virmani, “Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications,” Circulation 115(8), 1051–1058 (2007).
[Crossref] [PubMed]

G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, O. Valsecchi, G. S. Mintz, O. Dressler, H. Parise, A. Maehara, E. Cristea, A. J. Lansky, R. Mehran, and G. W. Stone, “Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial,” Circulation 123(3), 274–281 (2011).
[Crossref] [PubMed]

A. V. Finn, M. Joner, G. Nakazawa, F. Kolodgie, J. Newell, M. C. John, H. K. Gold, and R. Virmani, “Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization,” Circulation 115(18), 2435–2441 (2007).
[Crossref] [PubMed]

Data Min. Knowl. Discov. (1)

C. J. C. Burges, “A Tutorial on Support Vector Machines for Pattern Recognition,” Data Min. Knowl. Discov. 2(2), 121–167 (1998).
[Crossref]

Eur. Heart J. (2)

M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, and R. J. de Winter, “Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study,” Eur. Heart J. 31(9), 1055–1064 (2010).
[Crossref] [PubMed]

P. W. Serruys, H. M. Garcia-Garcia, and Y. Onuma, “From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?” Eur. Heart J. 33(1), 16–25 (2012).
[Crossref] [PubMed]

Eur. Heart J. Cardiovasc. Imaging (1)

G. J. Ughi, C. J. Van Dyck, T. Adriaenssens, V. Y. Hoymans, P. Sinnaeve, J.-P. Timmermans, W. Desmet, C. J. Vrints, and J. D’hooge, “Automatic assessment of stent neointimal coverage by intravascular optical coherence tomography,” Eur. Heart J. Cardiovasc. Imaging 15(2), 195–200 (2014).
[Crossref] [PubMed]

EuroIntervention (5)

J. M. Fam, C. Felix, R. J. van Geuns, Y. Onuma, N. M. Van Mieghem, A. Karanasos, J. van der Sijde, M. De Paolis, E. Regar, M. Valgimigli, J. Daemen, P. de Jaegere, F. Zijlstra, and R. Diletti, “Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study,” EuroIntervention 12(1), 30–37 (2016).
[Crossref] [PubMed]

D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino, “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention 10(10), 1144–1153 (2015).
[Crossref] [PubMed]

Y. Ishibashi, S. Nakatani, and Y. Onuma, “Definite and probable bioresorbable scaffold thrombosis in stable and ACS patients,” EuroIntervention 11(3), e1–e2 (2015).
[Crossref] [PubMed]

Y. Onuma, Y. Sotomi, H. Shiomi, Y. Ozaki, A. Namiki, S. Yasuda, T. Ueno, K. Ando, J. Furuya, K. Igarashi, K. Kozuma, K. Tanabe, H. Kusano, R. Rapoza, J. J. Popma, G. W. Stone, C. Simonton, P. W. Serruys, and T. Kimura, “Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial,” EuroIntervention 12(9), 1090–1101 (2016).
[Crossref] [PubMed]

B. Chevalier, Y. Onuma, A. J. van Boven, J. J. Piek, M. Sabaté, S. Helqvist, A. Baumbach, P. C. Smits, R. Kumar, L. Wasungu, and P. W. Serruys, “Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial,” EuroIntervention 12(9), 1102–1107 (2016).
[Crossref] [PubMed]

IEEE Trans. Med. Imaging (1)

M. W. Zhao Wang, G. C. Jenkins, H. G. Linderman, Y. Bezerra, M. A. Fujino, D. L. Costa, Wilson, and A. M. Rollins, “3-D Stent Detection in Intravascular OCT Using a Bayesian Network and Graph Search,” IEEE Trans. Med. Imaging 34(7), 1549–1561 (2015).
[Crossref] [PubMed]

IEEE Trans. Neural Netw. (1)

V. N. Vapnik, “An overview of statistical learning theory,” IEEE Trans. Neural Netw. 10(5), 988–999 (1999).
[Crossref] [PubMed]

Int. J. Cardiovasc. Imaging (3)

T. Adriaenssens, G. J. Ughi, C. Dubois, K. Onsea, D. De Cock, J. Bennett, S. Wiyono, M. Vanhaverbeke, P. Sinnaeve, A. Belmans, J. D’hooge, and W. Desmet, “Automated detection and quantification of clusters of malapposed and uncovered intracoronary stent struts assessed with optical coherence tomography,” Int. J. Cardiovasc. Imaging 30(5), 839–848 (2014).
[Crossref] [PubMed]

G. F. Attizzani and H. G. Bezerra, “Contemporary assessment of stent strut coverage by OCT,” Int. J. Cardiovasc. Imaging 29(1), 23–27 (2013).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

J. Am. Coll. Cardiol. (4)

M. Joner, A. V. Finn, A. Farb, E. K. Mont, F. D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H. K. Gold, and R. Virmani, “Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk,” J. Am. Coll. Cardiol. 48(1), 193–202 (2006).
[Crossref] [PubMed]

A. T. L. Ong, E. P. McFadden, E. Regar, P. P. T. de Jaegere, R. T. van Domburg, and P. W. Serruys, “Late angiographic stent thrombosis (LAST) events with drug-eluting stents,” J. Am. Coll. Cardiol. 45(12), 2088–2092 (2005).
[Crossref] [PubMed]

M. Pfisterer, H. P. Brunner-La Rocca, P. T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, C. Kaiser, and BASKET-LATE Investigators, “Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents,” J. Am. Coll. Cardiol. 48(12), 2584–2591 (2006).
[Crossref] [PubMed]

I.-K. Jang, B. E. Bouma, D.-H. Kang, S.-J. Park, S.-W. Park, K.-B. Seung, K.-B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S. L. Houser, H. T. Aretz, and G. J. Tearney, “Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound,” J. Am. Coll. Cardiol. 39(4), 604–609 (2002).
[Crossref] [PubMed]

J. Biomed. Opt. (2)

Z. Wang, H. Kyono, H. G. Bezerra, H. Wang, M. Gargesha, C. Alraies, C. Xu, J. M. Schmitt, D. L. Wilson, M. A. Costa, and A. M. Rollins, “Semiautomatic segmentation and quantification of calcified plaques in intracoronary optical coherence tomography images,” J. Biomed. Opt. 15(6), 061711 (2010).
[Crossref] [PubMed]

J. M. Amrute, L. S. Athanasiou, F. Rikhtegar, J. M. de la Torre Hernández, T. G. Camarero, and E. R. Edelman, “Polymeric endovascular strut and lumen detection algorithm for intracoronary optical coherence tomography images,” J. Biomed. Opt. 23(3), 1–14 (2018).
[Crossref] [PubMed]

J. Invasive Cardiol. (1)

R. Waksman, “Biodegradable stents: they do their job and disappear,” J. Invasive Cardiol. 18(2), 70–74 (2006).
[PubMed]

J. Med. Imaging (Bellingham) (1)

C. Kolluru, D. Prabhu, Y. Gharaibeh, H. Bezerra, G. Guagliumi, and D. Wilson, “Deep neural networks for A-line-based plaque classification in coronary intravascular optical coherence tomography images,” J. Med. Imaging (Bellingham) 5(4), 044504 (2018).
[Crossref] [PubMed]

JACC Cardiovasc. Interv. (3)

H. G. Bezerra, M. A. Costa, G. Guagliumi, A. M. Rollins, and D. I. Simon, “Intracoronary optical coherence tomography: a comprehensive review clinical and research applications,” JACC Cardiovasc. Interv. 2(11), 1035–1046 (2009).
[Crossref] [PubMed]

G. Guagliumi, V. Sirbu, G. Musumeci, R. Gerber, G. Biondi-Zoccai, H. Ikejima, E. Ladich, N. Lortkipanidze, A. Matiashvili, O. Valsecchi, R. Virmani, and G. W. Stone, “Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging,” JACC Cardiovasc. Interv. 5(1), 12–20 (2012).
[Crossref] [PubMed]

C. M. Felix, J. M. Fam, R. Diletti, Y. Ishibashi, A. Karanasos, B. R. C. Everaert, N. M. D. A. van Mieghem, J. Daemen, P. P. T. de Jaegere, F. Zijlstra, E. S. Regar, Y. Onuma, and R.-J. M. van Geuns, “Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry,” JACC Cardiovasc. Interv. 9(16), 1652–1663 (2016).
[Crossref] [PubMed]

Lancet (1)

P. W. Serruys, B. Chevalier, Y. Sotomi, A. Cequier, D. Carrié, J. J. Piek, A. J. Van Boven, M. Dominici, D. Dudek, D. McClean, S. Helqvist, M. Haude, S. Reith, M. de Sousa Almeida, G. Campo, A. Iñiguez, M. Sabaté, S. Windecker, and Y. Onuma, “Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial,” Lancet 388(10059), 2479–2491 (2016).
[Crossref] [PubMed]

Med. Phys. (2)

S. Tsantis, G. C. Kagadis, K. Katsanos, D. Karnabatidis, G. Bourantas, and G. C. Nikiforidis, “Automatic vessel lumen segmentation and stent strut detection in intravascular optical coherence tomography,” Med. Phys. 39(1), 503–513 (2011).
[Crossref] [PubMed]

H. S. Nam, C.-S. Kim, J. J. Lee, J. W. Song, J. W. Kim, and H. Yoo, “Automated detection of vessel lumen and stent struts in intravascular optical coherence tomography to evaluate stent apposition and neointimal coverage,” Med. Phys. 43(4), 1662–1675 (2016).
[Crossref] [PubMed]

Phys. Med. Biol. (1)

C. Xu, J. M. Schmitt, T. Akasaka, T. Kubo, and K. Huang, “Automatic detection of stent struts with thick neointimal growth in intravascular optical coherence tomography image sequences,” Phys. Med. Biol. 56(20), 6665–6675 (2011).
[Crossref] [PubMed]

Prog. Polym. Sci. (1)

S. McMahon, N. Bertollo, E. D. O. Cearbhaill, J. Salber, L. Pierucci, P. Duffy, T. Dürig, V. Bi, and W. Wang, “Bio-resorbable polymer stents: a review of material progress and prospects,” Prog. Polym. Sci. 83, 79–96 (2018).
[Crossref]

Other (8)

S. Gurmeric, G. G. Isguder, S. Carlier, and G. Unal, “A new 3-D automated computational method to evaluate in-stent neointimal hyperplasia in in-vivo intravascular optical coherence tomography pullbacks,” Med Image Comput Comput Assist Interv 12(Pt 2), 776–785 (2009).

N. Bruining, K. Sihan, J. Ligthart, S. de Winter, and E. Regar, “Automated three-dimensional detection of intracoronary stent struts in optical coherence tomography images,” in 2011 Computing in Cardiology (2011), pp. 221–224.

D. Prabhu, E. Mehanna, M. Gargesha, D. Wen, E. Brandt, N. S. van Ditzhuijzen, D. Chamie, H. Yamamoto, Y. Fujino, A. Farmazilian, J. Patel, M. Costa, H. G. Bezerra, and D. L. Wilson, “3D registration of intravascular optical coherence tomography and cryo-image volumes for microscopic-resolution validation,” Proc SPIE Int Soc Opt Eng9788, (2016).

R. Shalev, D. Prabhu, K. Tanaka, A. M. Rollins, M. Costa, H. G. Bezerra, R. Soumya, and D. L. Wilson, “Intravascular optical coherence tomography image analysis method,” in 2015 41st Annual Northeast Biomedical Engineering Conference (NEBEC) (2015), pp. 1–2.
[Crossref]

C. M. Bishop, Pattern Recognition and Machine Learning (Information Science and Statistics) (Springer-Verlag, 2006).

C.-C. Chang and C.-J. Lin, “LIBSVM: A Library for Support Vector Machines,” ACM Trans. Intell. Syst. Technol. 2(3), 27:1–27:27 (2011).
[Crossref]

R. Shalev, H. G. Bezerra, S. Ray, D. Prabhu, and D. L. Wilson, “Classification of calcium in intravascular OCT images for the purpose of intervention planning,” Proc SPIE Int Soc Opt Eng9786, (2016).

C. Kolluru, D. Prabhu, Y. Gharaibeh, H. Wu, and D. L. Wilson, “Voxel-based plaque classification in coronary intravascular optical coherence tomography images using decision trees,” Proc SPIE Int Soc Opt Eng10575, (2018).
[Crossref]

Cited By

OSA participates in Crossref's Cited-By Linking service. Citing articles from OSA journals and other participating publishers are listed here.

Alert me when this article is cited.


Figures (11)

Fig. 1
Fig. 1 IVOCT image with stent struts in polar (r, θ) coordinate (A) and Cartesian (x, y) coordinate (B). In B, red arrows point to uncovered struts and green arrows point to covered struts.
Fig. 2
Fig. 2 Examples of covered and uncovered struts. Left: covered strut satisfies two manual criteria: smooth, uniform coverage on top of it (red arrow) and continuous, smooth strut-tissue boundary in angular direction (yellow arrows). Right: uncovered strut lacks tissue coverage on top of it (red arrow) or at strut-tissue boundary in angular direction (yellow arrows).
Fig. 3
Fig. 3 Pixel patches for feature extraction in uncovered, thinly covered and thickly covered struts. Strut (red), middle (blue), front (green), and back (purple) patches are used to capture intensity features in radial direction. Side patches (orange) capture the tissue continuity in angular direction.
Fig. 4
Fig. 4 Strut-level tissue coverage thickness measurement. A. Global lumen boundary is inaccurate sometimes when struts are present. B. Lumen boundary in strut region is corrected by applying dynamic programming locally. C. Tissue thickness is measured from the covered strut center (green) to its closest-distance (magenta) point on the lumen boundary (cyan). D. Strut to lumen distance measured from uncovered strut center (red) to its closest distance (magenta) point on the lumen boundary (cyan).
Fig. 5
Fig. 5 ROC curve for identifying uncovered struts using the probabilistic output of SVM. After the active learning, relabeling step, area under ROC improved to 0.97 from 0.92.
Fig. 6
Fig. 6 Strut examples with different levels of classification difficulty. Top row (A), covered struts with thick tissue coverage and clearly uncovered struts were easy to classify. Middle row (B), covered struts with thin tissue coverage and uncovered strut tightly apposed to the vessel wall or with a thick appearance were challenging. Bottom row (C), the algorithm misclassified these entries as compared to an expert. Misclassification happened to covered struts with very thin tissue coverage and uncovered struts with a thick appearance or when residual blood was present.
Fig. 7
Fig. 7 Specificity for identifying uncovered struts increased as the coverage thickness of covered struts increased. After relabeling (data training improvement), specificity for struts with thinner tissue coverage was significantly improved.
Fig. 8
Fig. 8 Inter- and intra-observer agreement. A. Compare three observers to a standard established by the consensus of two other expert analysts. B. Analyze intra-observer agreement by comparing each of two observers at two time points with the earlier time point designated as the “gold standard.” C. Compare software performance to standard. In this test, we used the classifier trained on the other 80 pullbacks without relabeling.
Fig. 9
Fig. 9 Comparison of manual and automatic measurements of strut level tissue thickness. A. Histogram of errors on 39,000 struts. The very few large errors due to lumen segmentation errors can be avoided with manual correction of the lumen contour. B. Correlation between automatic and manual measurements after removing 5% outliers. Because it is impossible to plot 39,000 data points, we have created a color code showing that there are a very large number of samples at some data point locations.
Fig. 10
Fig. 10 Uncovered strut cluster on the 2D surface of a stent mesh. Struts in white are covered and those in red are individual uncovered struts. Polygons in other colors enclose clusters of uncovered struts.
Fig. 11
Fig. 11 3D visualization of stent. A. Blood vessel wall is rendered in gold and stent is in grey. B. Vessel wall is removed. Lumen is rendered in red. Uncovered struts are in white and struts with different tissue coverage thickness are color coded in blue and green.

Tables (2)

Tables Icon

Table 1 Features for Strut Classification

Tables Icon

Algorithm 1 Pseudo code of MG algorithm

Equations (2)

Equations on this page are rendered with MathJax. Learn more.

arg min w, ξ i    1 2 w 2 +C i=1 N ξ i  ,    y i ( w T ϕ( x i )+b )1 ξ i  and  ξ i   0  
κ( x i , x j ,σ )=exp( x i x j 2 2 σ 2 ) 

Metrics